STUDYID,DOMAIN,USUBJID,SUBJID,RFSTDTC,RFENDTC,RFXSTDTC,RFXENDTC,RFICDTC,RFPENDTC,DTHDTC,DTHFL,SITEID,AGE,AGEU,SEX,RACE,ETHNIC,ARMCD,ARM,ACTARMCD,ACTARM,COUNTRY,DMDTC,DMDY,AESEQ,AESPID,AETERM,AELLT,AELLTCD,AEDECOD,AEPTCD,AEHLT,AEHLTCD,AEHLGT,AEHLGTCD,AEBODSYS,AEBDSYCD,AESOC,AESOCCD,AESEV,AESER,AEACN,AEREL,AEOUT,AESCAN,AESCONG,AESDISAB,AESDTH,AESHOSP,AESLIFE,AESOD,AEDTC,AESTDTC,AEENDTC,AESTDY,AEENDY
CDISCPILOT01,AE,01-701-1015,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,1,E07,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-16,2014-01-03,NA,2,NA
CDISCPILOT01,AE,01-701-1015,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,2,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-16,2014-01-03,NA,2,NA
CDISCPILOT01,AE,01-701-1015,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,3,E06,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-16,2014-01-09,2014-01-11,8,10
CDISCPILOT01,AE,01-701-1023,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,3,E10,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-27,2012-08-26,NA,22,NA
CDISCPILOT01,AE,01-701-1023,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,1,E08,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-27,2012-08-07,2012-08-30,3,26
CDISCPILOT01,AE,01-701-1023,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,2,E09,ERYTHEMA,LOCALIZED ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-27,2012-08-07,NA,3,NA
CDISCPILOT01,AE,01-701-1023,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,4,E08,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-02,2012-08-07,2012-08-30,3,26
CDISCPILOT01,AE,01-701-1028,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,1,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-01,2013-07-21,NA,3,NA
CDISCPILOT01,AE,01-701-1028,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,2,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-14,2013-08-08,NA,21,NA
CDISCPILOT01,DM,01-701-1033,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-701-1034,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,1,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-09-25,2014-08-27,NA,58,NA
CDISCPILOT01,AE,01-701-1034,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,2,E07,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-11-18,2014-11-02,NA,125,NA
CDISCPILOT01,AE,01-701-1047,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,4,E09,BUNDLE BRANCH BLOCK LEFT,LEFT BUNDLE BRANCH BLOCK,NA,BUNDLE BRANCH BLOCK LEFT,NA,HLT_0281,NA,HLGT_0721,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-10,2013-03-10,NA,27,NA
CDISCPILOT01,AE,01-701-1047,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,1,E06,HIATUS HERNIA,HERNIA HIATAL,NA,HIATUS HERNIA,NA,HLT_0159,NA,HLGT_0109,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-12,2013-02-12,2013-02-12,1,1
CDISCPILOT01,AE,01-701-1047,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,2,E06,HIATUS HERNIA,HERNIA HIATAL,NA,HIATUS HERNIA,NA,HLT_0159,NA,HLGT_0109,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-25,2013-02-12,2013-02-12,1,1
CDISCPILOT01,AE,01-701-1047,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,3,E08,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-10,2013-03-06,NA,23,NA
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,4,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-26,2014-02-21,NA,52,NA
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,10,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-21,2014-02-21,NA,52,NA
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,3,E07,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-26,2014-02-20,2014-02-22,51,53
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,1,E04,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-15,2014-01-03,NA,3,NA
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,9,E11,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-23,2014-04-19,2014-04-22,109,112
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,8,E10,PHARYNGOLARYNGEAL PAIN,SORE THROAT,NA,PHARYNGOLARYNGEAL PAIN,NA,HLT_0130,NA,HLGT_0402,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-23,2014-04-19,2014-04-22,109,112
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,2,E05,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-26,2014-02-20,2014-02-20,51,51
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,5,E08,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-26,2014-03-21,2014-03-21,80,80
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,6,E12,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-23,2014-03-31,2014-03-31,90,90
CDISCPILOT01,AE,01-701-1097,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,7,E09,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-23,2014-04-19,2014-04-20,109,110
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,7,E16,ARTHRALGIA,GENERALIZED JOINT PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-17,2012-09-13,NA,7,NA
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,8,E17,CELLULITIS,CELLULITIS OF LEG,NA,CELLULITIS,NA,HLT_0613,NA,HLGT_0066,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-17,2012-09-13,NA,7,NA
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,1,E14,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-05,2012-09-02,2012-09-07,-5,1
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,4,E14,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-17,2012-09-02,2012-09-07,-5,1
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,3,E06,LOCALISED INFECTION,LOCALIZED INFECTION,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-17,2012-07-08,NA,-61,NA
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,6,E18,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-17,2012-09-07,NA,1,NA
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,2,E15,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-05,2012-09-02,2012-09-07,-5,1
CDISCPILOT01,AE,01-701-1111,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,5,E15,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-17,2012-09-02,2012-09-07,-5,1
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,9,E14,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-23,2013-01-19,NA,51,NA
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,1,E09,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-13,2012-12-02,NA,3,NA
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,5,E09,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-23,2012-12-02,NA,3,NA
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,3,E10,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-26,2012-12-26,2012-12-26,27,27
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,4,E10,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-28,2012-12-26,2012-12-26,27,27
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,8,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-23,2013-01-19,NA,51,NA
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,2,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-13,2012-12-02,NA,3,NA
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,6,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-23,2012-12-02,NA,3,NA
CDISCPILOT01,AE,01-701-1115,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,7,E13,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-23,2013-01-14,NA,46,NA
CDISCPILOT01,AE,01-701-1118,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,1,E06,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-10,2003,NA,NA,NA
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,5,E09,EYE ALLERGY,EYE ALLERGY,NA,EYE ALLERGY,NA,HLT_0256,NA,HLGT_0071,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-05-16,2014-05-09,2014-05-09,84,84
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,6,E10,EYE PRURITUS,EYE ITCHING,NA,EYE PRURITUS,NA,HLT_0523,NA,HLGT_0240,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-07,2014-05-22,NA,97,NA
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,4,E08,EYE SWELLING,EYES SWOLLEN,NA,EYE SWELLING,NA,HLT_0008,NA,HLGT_0466,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-05-16,2014-05-09,2014-05-09,84,84
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,8,E12,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-07,2014-05-22,NA,97,NA
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,7,E11,PRURITUS,ITCHING BOTH HANDS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-07,2014-05-22,NA,97,NA
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,2,E07,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-15,2014-03-09,2014-03-09,23,23
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,1,E06,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-15,2014-03-09,2014-03-16,23,30
CDISCPILOT01,AE,01-701-1130,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,3,E06,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-17,2014-03-09,2014-03-16,23,30
CDISCPILOT01,AE,01-701-1133,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,1,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-22,2012-12-27,NA,61,NA
CDISCPILOT01,AE,01-701-1133,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,3,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-18,2012-12-27,NA,61,NA
CDISCPILOT01,AE,01-701-1133,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,2,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-22,2012-12-27,NA,61,NA
CDISCPILOT01,AE,01-701-1133,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,4,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-18,2012-12-27,NA,61,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,5,E12,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-16,2013-06-10,NA,22,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,7,E12,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-30,2013-06-10,NA,22,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,3,E10,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-03,2013-06-01,2013-06-02,13,14
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,11,E16,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-30,2013-06-26,NA,38,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,9,E14,APPLICATION SITE PAIN,APPLICATION SITE PAIN,NA,APPLICATION SITE PAIN,NA,HLT_0342,NA,HLGT_0085,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-30,2013-06-22,NA,34,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,6,E13,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-16,2013-06-10,NA,22,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,8,E13,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-30,2013-06-10,NA,22,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,10,E15,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-30,2013-06-26,NA,38,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,4,E11,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-03,2013-06-03,NA,15,NA
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,1,E09,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-18,2013-05-16,2013-06-02,-4,14
CDISCPILOT01,AE,01-701-1146,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,2,E09,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-03,2013-05-16,2013-06-02,-4,14
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,10,E27,ACTINIC KERATOSIS,ACTINIC KERATOSIS,NA,ACTINIC KERATOSIS,NA,HLT_0609,NA,HLGT_0490,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-20,2014-02-12,NA,174,NA
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,1,E20,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-05,2013-08-25,NA,3,NA
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,2,E21,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-05,2013-08-25,NA,3,NA
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,6,E25,CALCULUS URETHRAL,URETHRAL CALCULUS,NA,CALCULUS URETHRAL,NA,HLT_0550,NA,HLGT_0414,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-10,2013-12-17,2013-12-17,117,117
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,9,E26,DEPRESSED MOOD,DEPRESSED MOOD,NA,DEPRESSED MOOD,NA,HLT_0784,NA,HLGT_0122,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-08,2013-07-29,NA,-25,NA
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,8,E03,DYSPEPSIA,INDIGESTION,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-08,2012-02,NA,NA,NA
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,7,E28,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-10,2014-01-03,2014-01-03,134,134
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,5,E24,FLANK PAIN,FLANK PAIN,NA,FLANK PAIN,NA,HLT_0484,NA,HLGT_0543,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-10,2013-12-15,2013-12-17,115,117
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,3,E23,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,NA,LOWER RESPIRATORY TRACT INFECTION,NA,HLT_0052,NA,HLGT_0217,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-18,2013-10-12,2013-11-10,51,80
CDISCPILOT01,AE,01-701-1148,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,4,E23,LOWER RESPIRATORY TRACT INFECTION,CHEST COLD,NA,LOWER RESPIRATORY TRACT INFECTION,NA,HLT_0052,NA,HLGT_0217,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-17,2013-10-12,2013-11-10,51,80
CDISCPILOT01,AE,01-701-1153,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,1,E06,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-19,2013-10-13,2013-11-06,21,45
CDISCPILOT01,AE,01-701-1153,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,2,E06,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-18,2013-10-13,2013-11-06,21,45
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,9,E07,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-23,2013-03-19,NA,36,NA
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,8,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-23,2013-03-19,NA,36,NA
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,7,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-23,2013-03-19,NA,36,NA
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,4,E04,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-11,2002,NA,NA,NA
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,3,E02,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-25,2013-02-15,2013-03-19,4,36
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,6,E02,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-23,2013-02-15,2013-03-19,4,36
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,5,E03,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-11,2013-03-06,2013-03-07,23,24
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,1,E01,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-12,2013-02-12,2013-02-12,1,1
CDISCPILOT01,AE,01-701-1180,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,2,E01,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-25,2013-02-12,2013-02-12,1,1
CDISCPILOT01,AE,01-701-1181,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,1,E16,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-12,2013-12-09,2013-12-09,5,5
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,7,E09,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-25,2013-03-21,NA,35,NA
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,1,E04,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-02,2013-02-16,NA,2,NA
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,3,E04,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-16,2013-02-16,NA,2,NA
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,2,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-02,2013-02-16,NA,2,NA
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,4,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-16,2013-02-16,NA,2,NA
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,5,E06,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-16,2013-03-04,NA,18,NA
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,6,E06,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-25,2013-03-04,NA,18,NA
CDISCPILOT01,AE,01-701-1188,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,8,E10,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-25,2013-03-21,NA,35,NA
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,13,E13,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-13,2012-12-05,NA,137,NA
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,12,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-13,2012-12-05,2012-12-16,137,148
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,15,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-11,2012-12-05,2012-12-16,137,148
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,14,E14,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-13,2012-12-05,NA,137,NA
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,4,E01,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-23,2010-06,NA,NA,NA
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,9,E01,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-14,2010-06,NA,NA,NA
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,3,E09,ERYTHEMA,ERYTHEMA FACIAL,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-07,2012-08-07,2012-09-14,17,55
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,6,E09,ERYTHEMA,ERYTHEMA FACIAL,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-23,2012-08-07,2012-09-14,17,55
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,8,E11,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,NA,MUSCULAR WEAKNESS,NA,HLT_0444,NA,HLGT_0211,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-23,2012-09-07,2012-09-30,48,71
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,11,E11,MUSCULAR WEAKNESS,MUSCULAR WEAKNESS,NA,MUSCULAR WEAKNESS,NA,HLT_0444,NA,HLGT_0211,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-14,2012-09-07,2012-09-30,48,71
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,1,E06,NASAL MUCOSA BIOPSY,NASAL MUCOSA BIOPSY,NA,NASAL MUCOSA BIOPSY,NA,HLT_0680,NA,HLGT_0396,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-08-07,2012-08-03,2012-08-03,13,13
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,7,E10,PNEUMONIA,PNEUMONIA,NA,PNEUMONIA,NA,HLT_0251,NA,HLGT_0671,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,2012-09-23,2012-09-07,2012-10-06,48,77
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,10,E10,PNEUMONIA,PNEUMONIA,NA,PNEUMONIA,NA,HLT_0251,NA,HLGT_0671,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2012-10-14,2012-09-07,2012-10-06,48,77
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,2,E08,SECRETION DISCHARGE,SECRETION DISCHARGE,NA,SECRETION DISCHARGE,NA,HLT_0683,NA,HLGT_0575,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-07,2012-08-07,2012-09-14,17,55
CDISCPILOT01,AE,01-701-1192,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,5,E08,SECRETION DISCHARGE,SECRETION DISCHARGE,NA,SECRETION DISCHARGE,NA,HLT_0683,NA,HLGT_0575,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-23,2012-08-07,2012-09-14,17,55
CDISCPILOT01,AE,01-701-1203,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,1,E05,EYE LASER SURGERY,EYE LASER SURGERY,NA,EYE LASER SURGERY,NA,HLT_0355,NA,HLGT_0189,NA,SURGICAL AND MEDICAL PROCEDURES,NA,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-21,2013-03-21,48,48
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,5,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-11,2012-11-29,NA,15,NA
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,1,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-28,2012-11-16,NA,2,NA
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,7,E12,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-14,2013-01-11,NA,58,NA
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,8,E13,DYSPNOEA,SHORTNESS OF BREATH,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-14,2013-01-11,NA,58,NA
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,4,E09,INCONTINENCE,INCONTINENCE,NA,INCONTINENCE,NA,HLT_0560,NA,HLGT_0503,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-28,2012-11-22,NA,8,NA
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,2,E03,JOINT DISLOCATION,SHOULDER DISLOCATION,NA,JOINT DISLOCATION,NA,HLT_0035,NA,HLGT_0227,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-11-28,2012-11-21,2012-11-21,7,7
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,3,E04,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-28,2012-11-21,NA,7,NA
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,6,E06,SKIN LACERATION,LACERATION OF FACE,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-11,2012-12-09,NA,25,NA
CDISCPILOT01,AE,01-701-1211,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,20,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,9,E11,SUDDEN DEATH,SUDDEN DEATH,NA,SUDDEN DEATH,NA,HLT_0142,NA,HLGT_0272,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,NONE,FATAL,N,N,N,Y,N,Y,N,2013-01-14,2013-01-14,2013-01-14,61,61
CDISCPILOT01,DM,01-701-1234,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,4,E13,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-25,2014-01-20,2014-02-08,10,29
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,5,E13,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-10,2014-01-20,2014-02-08,10,29
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,1,E11,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-25,2014-01-12,NA,2,NA
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,6,E11,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-19,2014-01-12,NA,2,NA
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,9,E16,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-02,2014-03,NA,NA,NA
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,10,E17,HORDEOLUM,STYE,NA,HORDEOLUM,NA,HLT_0604,NA,HLGT_0290,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-02,2014-04,NA,NA,NA
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,3,E12,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-25,2014-01-13,NA,3,NA
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,2,E15,SKIN ODOUR ABNORMAL,SKIN ODOR ABNORMAL,NA,SKIN ODOUR ABNORMAL,NA,HLT_0510,NA,HLGT_0184,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-25,2014-01-12,NA,2,NA
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,7,E14,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-06,2014-02-20,2014-03-12,41,61
CDISCPILOT01,AE,01-701-1239,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,8,E14,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-02,2014-02-20,2014-03-12,41,61
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,7,E09,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-22,2014-03-12,2014-03-27,34,49
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,9,E09,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-05,2014-03-12,2014-03-27,34,49
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,3,E06,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-07,2014-02-24,2014-06-12,18,126
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,12,E06,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-14,2014-02-24,2014-06-12,18,126
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,8,E10,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-22,2014-03-12,2014-03-27,34,49
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,10,E10,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-05,2014-03-12,2014-03-27,34,49
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,1,E04,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-22,2014-02-13,2014-06-03,7,117
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,11,E04,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-14,2014-02-13,2014-06-03,7,117
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,5,E08,PAROSMIA,STRANGE SMELL SENSATION,NA,PAROSMIA,NA,HLT_0258,NA,HLGT_0471,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-07,2014-02-24,2014-06-03,18,117
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,14,E08,PAROSMIA,STRANGE SMELL SENSATION,NA,PAROSMIA,NA,HLT_0258,NA,HLGT_0471,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-14,2014-02-24,2014-06-03,18,117
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,6,E11,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-07,2014-02-24,2014-06-12,18,126
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,15,E11,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-14,2014-02-24,2014-06-12,18,126
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,4,E07,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-07,2014-02-24,2014-06-03,18,117
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,13,E07,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-14,2014-02-24,2014-06-03,18,117
CDISCPILOT01,AE,01-701-1275,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,2,E05,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-07,2014-02-23,2014-02-23,17,17
CDISCPILOT01,AE,01-701-1287,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,3,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-21,2014-03-09,NA,44,NA
CDISCPILOT01,AE,01-701-1287,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,2,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-06,2014-02-22,NA,29,NA
CDISCPILOT01,AE,01-701-1287,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,4,E05,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-12,2014-07-09,2014-07-12,166,169
CDISCPILOT01,AE,01-701-1287,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,5,E05,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-26,2014-07-09,2014-07-12,166,169
CDISCPILOT01,AE,01-701-1287,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,1,E02,SALIVARY HYPERSECRETION,INCREASED SALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-11,2014-01-26,NA,2,NA
CDISCPILOT01,AE,01-701-1294,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,3,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-22,2013-05-19,NA,57,NA
CDISCPILOT01,AE,01-701-1294,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,5,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-14,2013-05-19,NA,57,NA
CDISCPILOT01,AE,01-701-1294,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,1,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-24,2013-03-22,2013-03-23,-2,-1
CDISCPILOT01,AE,01-701-1294,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,2,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-22,2013-05-19,NA,57,NA
CDISCPILOT01,AE,01-701-1294,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,4,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-14,2013-05-19,NA,57,NA
CDISCPILOT01,AE,01-701-1294,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,6,E09,RASH ERYTHEMATOUS,ERYTHEMATOUS RASH,NA,RASH ERYTHEMATOUS,NA,HLT_0336,NA,HLGT_0701,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-14,2013-06-10,NA,79,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,16,E27,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-22,2013-10-15,NA,48,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,1,E21,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-08-30,NA,2,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,17,E28,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-22,2013-10-15,NA,48,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,12,E19,CONTUSION,BRUISE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-05,2013-10-08,8,41
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,15,E19,CONTUSION,BRUISE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-22,2013-09-05,2013-10-08,8,41
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,9,E17,DIZZINESS,DIZZY,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-02,2013-09-03,5,6
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,11,E20,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-04,NA,7,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,14,E25,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-08,2013-09-30,NA,33,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,21,E31,FEELING ABNORMAL,FOGGY FEELING IN HEAD,NA,FEELING ABNORMAL,NA,HLT_0524,NA,HLGT_0749,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-05,2013-10-24,NA,57,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,13,E23,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-15,NA,18,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,2,E24,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-08-30,NA,2,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,23,E33,LIBIDO DECREASED,LIBIDO DECREASED,NA,LIBIDO DECREASED,NA,HLT_0338,NA,HLGT_0496,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-05,2013-10-24,NA,57,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,22,E32,LISTLESS,LISTLESSNESS,NA,LISTLESS,NA,HLT_0657,NA,HLGT_0124,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-05,2013-10-24,NA,57,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,8,E16,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-02,NA,5,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,18,E16,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-05,2013-09-02,NA,5,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,10,E18,MYALGIA,MYALGIA,NA,MYALGIA,NA,HLT_0700,NA,HLGT_0121,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-02,NA,5,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,5,E13,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-01,NA,4,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,4,E22,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-08-31,NA,3,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,6,E14,PHARYNGOLARYNGEAL PAIN,SORE THROAT,NA,PHARYNGOLARYNGEAL PAIN,NA,HLT_0130,NA,HLGT_0402,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-02,NA,5,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,7,E15,PRODUCTIVE COUGH,PRODUCTIVE COUGH,NA,PRODUCTIVE COUGH,NA,HLT_0545,NA,HLGT_0681,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-09-02,NA,5,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,19,E29,RESPIRATORY TRACT CONGESTION,RESPIRATORY TRACT CONGESTION,NA,RESPIRATORY TRACT CONGESTION,NA,HLT_0330,NA,HLGT_0424,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-05,2013-10-23,NA,56,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,20,E30,RHINITIS,CORYZA,NA,RHINITIS,NA,HLT_0239,NA,HLGT_0322,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-05,2013-10-23,NA,56,NA
CDISCPILOT01,AE,01-701-1302,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,3,E26,STOMACH DISCOMFORT,STOMACH UPSET,NA,STOMACH DISCOMFORT,NA,HLT_0065,NA,HLGT_0183,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-15,2013-08-30,NA,2,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,3,E13,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-03,2014-06-23,NA,33,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,4,E14,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-03,2014-06-23,NA,33,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,5,E15,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-03,2014-06-23,NA,33,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,2,E12,CYST,CYST,NA,CYST,NA,HLT_0763,NA,HLGT_0341,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-20,2014-05-13,NA,-9,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,6,E16,DEPRESSED MOOD,DEPRESSED MOOD,NA,DEPRESSED MOOD,NA,HLT_0784,NA,HLGT_0122,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-22,2014-07-04,NA,44,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,7,E16,DEPRESSED MOOD,DEPRESSED MOOD,NA,DEPRESSED MOOD,NA,HLT_0784,NA,HLGT_0122,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-10-09,2014-07-04,NA,44,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,9,E18,DYSPHONIA,HOARSENESS,NA,DYSPHONIA,NA,HLT_0073,NA,HLGT_0274,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-11-06,2014-11-03,NA,166,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,8,E17,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-10-09,2014-09-12,NA,114,NA
CDISCPILOT01,AE,01-701-1317,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,1,E11,ONYCHOMYCOSIS,ONYCHOMYCOSIS,NA,ONYCHOMYCOSIS,NA,HLT_0275,NA,HLGT_0243,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-20,2014-05-13,NA,-9,NA
CDISCPILOT01,AE,01-701-1324,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,1,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-30,2012-10-22,NA,21,NA
CDISCPILOT01,AE,01-701-1324,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,2,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-25,2012-12-02,NA,62,NA
CDISCPILOT01,AE,01-701-1324,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,3,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-25,2012-12-25,2013-01-16,85,107
CDISCPILOT01,AE,01-701-1324,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,4,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-22,2012-12-25,2013-01-16,85,107
CDISCPILOT01,AE,01-701-1341,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,2,E10,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-07,2013-01-19,NA,15,NA
CDISCPILOT01,AE,01-701-1341,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,4,E12,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-07,2013-01-26,NA,22,NA
CDISCPILOT01,AE,01-701-1341,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,5,E13,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-07,2013-01-26,2013-01-30,22,26
CDISCPILOT01,AE,01-701-1341,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,1,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-07,2013-01-19,NA,15,NA
CDISCPILOT01,AE,01-701-1341,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,3,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-07,2013-01-26,2013-01-30,22,26
CDISCPILOT01,DM,01-701-1345,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-701-1360,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,1,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-14,2013-08-02,NA,3,NA
CDISCPILOT01,AE,01-701-1360,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,2,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-14,2013-08-02,NA,3,NA
CDISCPILOT01,AE,01-701-1360,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,3,E10,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-14,2013-08-05,NA,6,NA
CDISCPILOT01,AE,01-701-1363,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,3,E11,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-24,2013-07-16,NA,48,NA
CDISCPILOT01,AE,01-701-1363,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,5,E13,BACK PAIN,BACKACHE,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-14,2013-10-13,2013-10-15,137,139
CDISCPILOT01,AE,01-701-1363,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,6,E13,BACK PAIN,BACKACHE,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-13,2013-10-13,2013-10-15,137,139
CDISCPILOT01,AE,01-701-1363,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,2,E03,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-24,1986,NA,NA,NA
CDISCPILOT01,AE,01-701-1363,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,4,E03,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-14,1986,NA,NA,NA
CDISCPILOT01,AE,01-701-1363,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,1,E09,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-25,2013-06-14,2013-06-15,16,17
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,3,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-02,2013-03-23,2013-03-26,48,51
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,5,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-30,2013-04-12,NA,68,NA
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,6,E09,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-30,2013-04-12,NA,68,NA
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,8,E09,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-30,2013-04-12,NA,68,NA
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,2,E05,APPLICATION SITE PAIN,APPLICATION SITE PAIN,NA,APPLICATION SITE PAIN,NA,HLT_0342,NA,HLGT_0085,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-19,2013-02-07,2013-02-07,4,4
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,1,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-19,2013-02-07,2013-02-07,4,4
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,4,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-02,2013-03-23,NA,48,NA
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,7,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-30,2013-03-23,NA,48,NA
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,9,E10,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-30,2013-05-07,2013-05-24,93,110
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,10,E11,CHEST DISCOMFORT,CHEST PRESSURE,NA,CHEST DISCOMFORT,NA,HLT_0593,NA,HLGT_0441,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-25,2013-06-24,2013-06-24,141,141
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,12,E13,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-30,2013-07-17,2013-07-26,164,173
CDISCPILOT01,AE,01-701-1383,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,11,E12,HEADACHE,FULLNESS HEAD,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-25,2013-06-24,2013-06-24,141,141
CDISCPILOT01,AE,01-701-1387,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,1,E08,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-25,2014-03-18,2014-03-18,7,7
CDISCPILOT01,AE,01-701-1387,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,2,E09,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-25,2014-03-18,2014-03-18,7,7
CDISCPILOT01,AE,01-701-1392,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,1,E04,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-17,2013-03-16,2013-03-21,140,145
CDISCPILOT01,AE,01-701-1392,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,2,E04,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-15,2013-03-16,2013-03-21,140,145
CDISCPILOT01,AE,01-701-1415,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,6,E12,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-10,2014-03-09,2014-03-09,168,168
CDISCPILOT01,AE,01-701-1415,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,3,E10,MICTURITION URGENCY,URINARY URGENCY,NA,MICTURITION URGENCY,NA,HLT_0294,NA,HLGT_0483,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-21,2013-12-02,NA,71,NA
CDISCPILOT01,AE,01-701-1415,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,1,E09,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-22,2013-10-21,2013-11-04,29,43
CDISCPILOT01,AE,01-701-1415,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,2,E09,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-21,2013-10-21,2013-11-04,29,43
CDISCPILOT01,AE,01-701-1415,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,4,E11,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-10,2014-01-21,2014-02-10,121,141
CDISCPILOT01,AE,01-701-1415,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,5,E11,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-10,2014-01-21,2014-02-10,121,141
CDISCPILOT01,DM,01-701-1429,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,DM,01-701-1440,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-701-1442,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,1,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-18,2014-01-10,NA,77,NA
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,1,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-31,2013-01-19,NA,15,NA
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,4,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-13,2013-01-19,NA,15,NA
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,6,E15,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-13,2013-02-04,NA,31,NA
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,2,E12,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-31,2013-01-19,NA,15,NA
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,5,E12,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-13,2013-01-19,NA,15,NA
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,7,E16,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-13,2013-02-04,NA,31,NA
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,8,E14,PARAESTHESIA,TINGLING,NA,PARAESTHESIA,NA,HLT_0481,NA,HLGT_0534,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-13,2013-02-08,2013-02-08,35,35
CDISCPILOT01,AE,01-701-1444,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,3,E13,SALIVARY HYPERSECRETION,HYPERSALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-31,2013-01-19,NA,15,NA
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,9,E07,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-28,2013-09-09,2013-09-24,46,61
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,2,E03,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,NA,NEUTROPHIL COUNT INCREASED,NA,HLT_0326,NA,HLGT_0625,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-24,2013-07-07,2013-07-26,-19,1
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,6,E03,NEUTROPHIL COUNT INCREASED,NEUTROPHIL COUNT INCREASED,NA,NEUTROPHIL COUNT INCREASED,NA,HLT_0326,NA,HLGT_0625,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-08,2013-07-07,2013-07-26,-19,1
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,7,E06,RECTAL HAEMORRHAGE,RECTAL BLEEDING,NA,RECTAL HAEMORRHAGE,NA,HLT_0353,NA,HLGT_0755,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-06,2013-09-02,2013-09-06,39,43
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,8,E06,RECTAL HAEMORRHAGE,RECTAL BLEEDING,NA,RECTAL HAEMORRHAGE,NA,HLT_0353,NA,HLGT_0755,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-28,2013-09-02,2013-09-06,39,43
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,10,E08,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-17,2013-10-12,2013-10-31,79,98
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,3,E04,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,NA,URINE ANALYSIS ABNORMAL,NA,HLT_0783,NA,HLGT_0295,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-24,2013-07-07,2013-07-24,-19,-2
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,4,E04,URINE ANALYSIS ABNORMAL,URINE ANALYSIS ABNORMAL,NA,URINE ANALYSIS ABNORMAL,NA,HLT_0783,NA,HLGT_0295,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-26,2013-07-07,2013-07-24,-19,-2
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,1,E02,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,NA,WHITE BLOOD CELL COUNT INCREASED,NA,HLT_0417,NA,HLGT_0465,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-24,2013-07-07,2013-07-26,-19,1
CDISCPILOT01,AE,01-702-1082,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,5,E02,WHITE BLOOD CELL COUNT INCREASED,WBC INCREASED,NA,WHITE BLOOD CELL COUNT INCREASED,NA,HLT_0417,NA,HLGT_0465,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-08,2013-07-07,2013-07-26,-19,1
CDISCPILOT01,AE,01-703-1042,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,1,E04,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-14,2013-03-04,2013-03-05,3,4
CDISCPILOT01,AE,01-703-1042,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,2,E05,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-14,2013-03-05,2013-03-06,4,5
CDISCPILOT01,AE,01-703-1076,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,5,E09,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-04,2013-11-23,NA,30,NA
CDISCPILOT01,AE,01-703-1076,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,4,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-04,2013-11-23,NA,30,NA
CDISCPILOT01,AE,01-703-1076,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,7,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-17,2013-11-23,NA,30,NA
CDISCPILOT01,AE,01-703-1076,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,2,E01,BENIGN PROSTATIC HYPERPLASIA,BENIGN PROSTATIC HYPERTROPHY,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-20,2013-11-20,NA,27,NA
CDISCPILOT01,AE,01-703-1076,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,1,E02,BIOPSY PROSTATE,BIOPSY OF PROSTATE,NA,BIOPSY PROSTATE,NA,HLT_0553,NA,HLGT_0725,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-20,2013-11-16,2013-11-16,23,23
CDISCPILOT01,AE,01-703-1076,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,3,E05,HYPERCHOLESTEROLAEMIA,HYPERCHOLESTEROLEMIA,NA,HYPERCHOLESTEROLAEMIA,NA,HLT_0025,NA,HLGT_0703,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-04,2007,NA,NA,NA
CDISCPILOT01,AE,01-703-1076,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,6,E07,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-04,2013-11-25,NA,32,NA
CDISCPILOT01,AE,01-703-1086,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,1,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-16,2012-09-13,2013-01-02,12,123
CDISCPILOT01,AE,01-703-1086,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,2,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-30,2012-09-13,2013-01-02,12,123
CDISCPILOT01,AE,01-703-1086,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,3,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-13,2012-09-13,2013-01-02,12,123
CDISCPILOT01,AE,01-703-1086,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,6,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-26,2012-09-13,2013-01-02,12,123
CDISCPILOT01,AE,01-703-1086,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,4,E02,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-13,2012-10-09,2012-10-15,38,44
CDISCPILOT01,AE,01-703-1086,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,5,E02,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-27,2012-10-09,2012-10-15,38,44
CDISCPILOT01,DM,01-703-1096,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,1,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-12,2013-04-05,2013-04-16,24,35
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,2,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-14,2013-04-05,2013-04-16,24,35
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,3,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-24,2013-04-05,2013-04-16,24,35
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,4,E06,CATARACT OPERATION,CATARACT EXTRACTION,NA,CATARACT OPERATION,NA,HLT_0432,NA,HLGT_0058,NA,SURGICAL AND MEDICAL PROCEDURES,NA,SURGICAL AND MEDICAL PROCEDURES,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-08,2013-04-25,2013-04-25,44,44
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,6,E07,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-02-28,2013-09-14,-13,186
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,8,E07,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-14,2013-02-28,2013-09-14,-13,186
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,7,E09,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-07-17,2013-09-14,127,186
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,9,E09,OEDEMA PERIPHERAL,LEG EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-14,2013-07-17,2013-09-14,127,186
CDISCPILOT01,AE,01-703-1100,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,5,E08,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-05,2013-05-27,2013-06-03,76,83
CDISCPILOT01,AE,01-703-1119,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,1,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-21,2013-03-16,NA,25,NA
CDISCPILOT01,AE,01-703-1119,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,2,E04,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-17,2013-03-16,NA,25,NA
CDISCPILOT01,AE,01-703-1119,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,3,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-17,2013-05-04,NA,74,NA
CDISCPILOT01,AE,01-703-1119,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,4,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-05-04,NA,74,NA
CDISCPILOT01,AE,01-703-1175,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,1,E01,ATRIOVENTRICULAR BLOCK SECOND DEGREE,HEART BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,SEVERE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-18,2013-12-18,NA,-2,NA
CDISCPILOT01,AE,01-703-1182,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,1,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-31,2013-10-31,NA,15,NA
CDISCPILOT01,AE,01-703-1182,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,2,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-28,2013-10-31,NA,15,NA
CDISCPILOT01,AE,01-703-1182,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,3,E07,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-28,2013-11-22,NA,37,NA
CDISCPILOT01,AE,01-703-1182,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,4,E07,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-12,2013-11-22,NA,37,NA
CDISCPILOT01,DM,01-703-1197,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-703-1210,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,2,E04,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-10,2013-05-04,NA,50,NA
CDISCPILOT01,AE,01-703-1210,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,3,E04,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-24,2013-05-04,NA,50,NA
CDISCPILOT01,AE,01-703-1210,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,1,E01,DISORIENTATION,DISORIENTATION,NA,DISORIENTATION,NA,HLT_0299,NA,HLGT_0307,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-12,2013-04-02,NA,18,NA
CDISCPILOT01,AE,01-703-1258,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,4,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-04,2012-09-04,2013-01-25,47,190
CDISCPILOT01,AE,01-703-1258,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,6,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-14,2012-09-04,2013-01-25,47,190
CDISCPILOT01,AE,01-703-1258,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,7,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-28,2012-09-04,2013-01-25,47,190
CDISCPILOT01,AE,01-703-1258,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,2,E06,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-04,2001,NA,NA,NA
CDISCPILOT01,AE,01-703-1258,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,5,E06,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-14,2001,NA,NA,NA
CDISCPILOT01,AE,01-703-1258,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,1,E07,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-17,2012-08-11,2012-08-19,23,31
CDISCPILOT01,AE,01-703-1258,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,3,E07,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-04,2012-08-11,2012-08-19,23,31
CDISCPILOT01,DM,01-703-1279,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-703-1295,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,1,E06,ARTHRITIS,ARTHRITIS,NA,ARTHRITIS,NA,HLT_0019,NA,HLGT_0587,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-01,2013-12-28,NA,38,NA
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,3,E01,GLAUCOMA,GLAUCOMA,NA,GLAUCOMA,NA,HLT_0556,NA,HLGT_0734,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-01,1992,NA,NA,NA
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,4,E05,HYPOTENSION,HYPOTENSION,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-01,2013-03-01,NA,171,NA
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,6,E05,HYPOTENSION,HYPOTENSION,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-13,2013-03-01,NA,171,NA
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,8,E07,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-13,2013-03-13,NA,183,NA
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,5,E06,TACHYCARDIA,TACHYCARDIA,NA,TACHYCARDIA,NA,HLT_0082,NA,HLGT_0574,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-01,2013-03-01,NA,171,NA
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,7,E06,TACHYCARDIA,TACHYCARDIA,NA,TACHYCARDIA,NA,HLT_0082,NA,HLGT_0574,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-13,2013-03-01,NA,171,NA
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,1,E02,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-28,2012-09-27,2012-10-06,16,25
CDISCPILOT01,AE,01-703-1299,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,2,E02,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-10,2012-09-27,2012-10-06,16,25
CDISCPILOT01,AE,01-703-1335,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,1,E01,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-15,2014-03-15,2014-03-30,-2,14
CDISCPILOT01,AE,01-703-1335,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,2,E01,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-31,2014-03-15,2014-03-30,-2,14
CDISCPILOT01,DM,01-703-1379,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-703-1403,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,4,E03,CHEST DISCOMFORT,CHEST TIGHTNESS,NA,CHEST DISCOMFORT,NA,HLT_0593,NA,HLGT_0441,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-19,2012-12-15,2012-12-16,4,5
CDISCPILOT01,AE,01-703-1403,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,2,E01,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-19,2012-12-13,2012-12-14,2,3
CDISCPILOT01,AE,01-703-1403,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,3,E02,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-19,2012-12-13,2012-12-14,2,3
CDISCPILOT01,AE,01-703-1403,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,1,E07,WEIGHT DECREASED,WEIGHT LOSS,NA,WEIGHT DECREASED,NA,HLT_0158,NA,HLGT_0778,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-19,2012-12-12,2012-12-19,1,8
CDISCPILOT01,AE,01-703-1403,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,5,E07,WEIGHT DECREASED,WEIGHT LOSS,NA,WEIGHT DECREASED,NA,HLT_0158,NA,HLGT_0778,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-08,2012-12-12,2012-12-19,1,8
CDISCPILOT01,AE,01-703-1439,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,1,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-05,2014-04-24,NA,44,NA
CDISCPILOT01,AE,01-703-1439,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,2,E01,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-30,2014-04-24,NA,44,NA
CDISCPILOT01,AE,01-704-1008,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,1,E03,HYPERHIDROSIS,SWEATING INCREASED,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-09,2013-01-30,NA,18,NA
CDISCPILOT01,AE,01-704-1008,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,3,E05,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-25,2013-02-25,NA,44,NA
CDISCPILOT01,AE,01-704-1008,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,2,E06,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-02-25,2013-02-21,2013-02-21,40,40
CDISCPILOT01,AE,01-704-1009,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,5,E07,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-02,2013-09-17,NA,22,NA
CDISCPILOT01,AE,01-704-1009,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,1,E09,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-14,2013-09-05,NA,10,NA
CDISCPILOT01,AE,01-704-1009,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,2,E10,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-14,2013-09-05,2013-09-27,10,32
CDISCPILOT01,AE,01-704-1009,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,4,E10,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-02,2013-09-05,2013-09-27,10,32
CDISCPILOT01,AE,01-704-1009,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,6,E08,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-02,2013-09-22,2013-09-23,27,28
CDISCPILOT01,AE,01-704-1009,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,3,E03,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-14,2013-09-14,NA,19,NA
CDISCPILOT01,AE,01-704-1010,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,6,E07,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-09,2014-07-06,NA,136,NA
CDISCPILOT01,AE,01-704-1010,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,7,E08,CONTUSION,BRUISE OF HEAD,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-09,2014-07-06,NA,136,NA
CDISCPILOT01,AE,01-704-1010,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,1,E01,CYSTITIS,BLADDER INFECTION,NA,CYSTITIS,NA,HLT_0739,NA,HLGT_0129,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-08,2014-02-27,2014-03-06,7,14
CDISCPILOT01,AE,01-704-1010,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,3,E04,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-09,2014-07-05,2014-07-06,135,136
CDISCPILOT01,AE,01-704-1010,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,4,E05,EXCORIATION,ABRASION NOS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-09,2014-07-06,NA,136,NA
CDISCPILOT01,AE,01-704-1010,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,5,E06,SKIN LACERATION,SKIN TEAR,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-09,2014-07-06,NA,136,NA
CDISCPILOT01,AE,01-704-1010,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,2,E03,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-09,2014-07-05,2014-07-06,135,136
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,4,E16,CARDIAC DISORDER,CARDIAC DISORDER,NA,CARDIAC DISORDER,NA,HLT_0507,NA,HLGT_0126,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-09,2013-11-01,NA,27,NA
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,3,E13,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-09,2013-11-01,2013-11-08,27,34
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,1,E14,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-19,2013-10-19,NA,14,NA
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,6,E12,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-09,2013-11-05,2013-11-22,31,48
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,8,E12,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-24,2013-11-05,2013-11-22,31,48
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,5,E11,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-09,2013-11-05,2013-11-22,31,48
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,7,E11,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-24,2013-11-05,2013-11-22,31,48
CDISCPILOT01,AE,01-704-1017,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,2,E15,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,NA,VENTRICULAR SEPTAL DEFECT,NA,HLT_0589,NA,HLGT_0747,NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-19,2013-10-19,NA,14,NA
CDISCPILOT01,AE,01-704-1025,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,3,E05,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-11,2013-10-11,2013-10-25,15,29
CDISCPILOT01,AE,01-704-1025,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,5,E05,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-29,2013-10-11,2013-10-25,15,29
CDISCPILOT01,AE,01-704-1025,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,2,E02,PALPITATIONS,PALPITATIONS,NA,PALPITATIONS,NA,HLT_0493,NA,HLGT_0593,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-11,2013-09-28,2013-09-30,2,4
CDISCPILOT01,AE,01-704-1025,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,1,E01,VERTIGO,VERTIGO,NA,VERTIGO,NA,HLT_0255,NA,HLGT_0147,NA,EAR AND LABYRINTH DISORDERS,NA,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-11,2013-09-28,2013-09-30,2,4
CDISCPILOT01,AE,01-704-1025,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,4,E06,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROM,NA,WOLFF-PARKINSON-WHITE SYNDROME,NA,HLT_0612,NA,HLGT_0218,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-25,2013-10-25,2013-11-29,29,64
CDISCPILOT01,AE,01-704-1025,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,6,E06,WOLFF-PARKINSON-WHITE SYNDROME,WOLFF-PARKINSON-WHITE SYNDROM,NA,WOLFF-PARKINSON-WHITE SYNDROME,NA,HLT_0612,NA,HLGT_0218,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-29,2013-10-25,2013-11-29,29,64
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,1,E13,ABDOMINAL DISCOMFORT,ABDOMINAL DISCOMFORT,NA,ABDOMINAL DISCOMFORT,NA,HLT_0012,NA,HLGT_0332,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-07,2013-10-26,NA,3,NA
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,4,E12,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-25,2013-11-09,NA,17,NA
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,3,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-07,2013-10-27,NA,4,NA
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,7,E16,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-25,2013-11-17,2013-11-17,25,25
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,9,E18,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-20,2013-12-15,2013-12-15,53,53
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,8,E17,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-25,2013-11-17,2013-11-17,25,25
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,6,E15,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-25,2013-11-09,NA,17,NA
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,5,E14,MALAISE,MALAISE,NA,MALAISE,NA,HLT_0456,NA,HLGT_0178,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-25,2013-11-09,NA,17,NA
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,2,E07,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-07,2013-10-27,NA,4,NA
CDISCPILOT01,AE,01-704-1065,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,10,E19,SINUS BRADYCARDIA,BRADYCARDIA SINUS,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-24,2013-12-24,NA,62,NA
CDISCPILOT01,AE,01-704-1074,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,2,E09,ERYTHEMA,SKIN RED,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-09,2014-02-09,NA,19,NA
CDISCPILOT01,AE,01-704-1074,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,1,E08,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-22,2014-01-22,NA,1,NA
CDISCPILOT01,AE,01-704-1093,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,1,E02,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-30,2013-04-13,16,30
CDISCPILOT01,AE,01-704-1093,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,2,E02,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-17,2013-03-30,2013-04-13,16,30
CDISCPILOT01,AE,01-704-1093,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,4,E06,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-11,2013-05-04,NA,51,NA
CDISCPILOT01,AE,01-704-1093,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,3,E05,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-11,2013-05-04,NA,51,NA
CDISCPILOT01,AE,01-704-1114,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,1,E06,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-13,2013-02-21,2013-02-23,30,32
CDISCPILOT01,AE,01-704-1114,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,5,E07,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-16,2013-06-07,2013-06-13,136,142
CDISCPILOT01,AE,01-704-1114,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,2,E03,OEDEMA,EDEMA,NA,OEDEMA,NA,HLT_0656,NA,HLGT_0036,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-13,2013-02-23,NA,32,NA
CDISCPILOT01,AE,01-704-1114,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,4,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-26,2013-03-23,NA,60,NA
CDISCPILOT01,AE,01-704-1114,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,3,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-26,2013-03-23,NA,60,NA
CDISCPILOT01,AE,01-704-1120,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,2,E02,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-29,2013-12-28,2014-02-03,27,64
CDISCPILOT01,AE,01-704-1120,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,6,E02,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-10,2013-12-28,2014-02-03,27,64
CDISCPILOT01,AE,01-704-1120,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,4,E04,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-27,2014-01-27,NA,57,NA
CDISCPILOT01,AE,01-704-1120,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,5,E04,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-03,2014-01-27,NA,57,NA
CDISCPILOT01,AE,01-704-1120,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,1,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-29,2013-12-23,NA,22,NA
CDISCPILOT01,AE,01-704-1120,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,3,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-27,2013-12-23,NA,22,NA
CDISCPILOT01,DM,01-704-1127,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-704-1135,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,1,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NA,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-11,2013-12-08,NA,39,NA
CDISCPILOT01,AE,01-704-1135,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,2,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,NA,NA,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-19,2013-12-08,NA,39,NA
CDISCPILOT01,AE,01-704-1164,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,1,E02,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-04,2012-09-27,2012-10-07,9,19
CDISCPILOT01,AE,01-704-1164,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,2,E02,INFLUENZA,FLU,NA,INFLUENZA,NA,HLT_0125,NA,HLGT_0081,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-21,2012-09-27,2012-10-07,9,19
CDISCPILOT01,AE,01-704-1164,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,3,E07,OEDEMA PERIPHERAL,SWELLING OF FEET,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-14,2013-02-04,2013-02-13,139,148
CDISCPILOT01,AE,01-704-1218,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,1,E05,BLOOD GLUCOSE INCREASED,GLUCOSE INCREASED,NA,BLOOD GLUCOSE INCREASED,NA,HLT_0450,NA,HLGT_0188,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-30,2012-12-30,NA,42,NA
CDISCPILOT01,DM,01-704-1233,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-704-1241,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,2,E03,DYSPNOEA,RESPIRATION LABORED,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-09,2013-09-28,NA,35,NA
CDISCPILOT01,AE,01-704-1241,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,1,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-09,2013-08-14,NA,-11,NA
CDISCPILOT01,DM,01-704-1260,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,4,E13,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-08,2013-11-08,2013-12-06,27,55
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,13,E13,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-03,2013-11-08,2013-12-06,27,55
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,3,E12,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-27,2013-10-27,2013-11-08,15,27
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,5,E12,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-10,2013-10-27,2013-11-08,15,27
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,7,E16,BLISTER,BLISTERING,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-22,2013-11-15,2013-12-14,34,63
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,14,E16,BLISTER,BLISTERING,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-03,2013-11-15,2013-12-14,34,63
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,2,E10,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-27,2013-10-17,2013-12-23,5,72
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,9,E10,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-06,2013-10-17,2013-12-23,5,72
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,12,E10,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-03,2013-10-17,2013-12-23,5,72
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,11,E18,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-06,2013-12-06,2013-12-23,55,72
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,16,E18,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-03,2013-12-06,2013-12-23,55,72
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,6,E15,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-10,2013-11-09,2013-12-04,28,53
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,10,E15,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-06,2013-11-09,2013-12-04,28,53
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,8,E17,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-22,2013-11-15,2013-12-23,34,72
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,15,E17,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-03,2013-11-15,2013-12-23,34,72
CDISCPILOT01,AE,01-704-1266,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,1,E11,SEASONAL ALLERGY,HAY FEVER,NA,SEASONAL ALLERGY,NA,HLT_0714,NA,HLGT_0782,NA,IMMUNE SYSTEM DISORDERS,NA,IMMUNE SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-11,2013-10-06,NA,-7,NA
CDISCPILOT01,AE,01-704-1323,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,4,E10,OEDEMA,EDEMA,NA,OEDEMA,NA,HLT_0656,NA,HLGT_0036,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-04,2013-08-04,NA,28,NA
CDISCPILOT01,AE,01-704-1323,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,3,E09,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-04,2013-08-04,NA,28,NA
CDISCPILOT01,AE,01-704-1323,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,2,E08,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-04,2013-08-04,NA,28,NA
CDISCPILOT01,AE,01-704-1323,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,1,E07,VIRAL INFECTION,VIRAL INFECTION,NA,VIRAL INFECTION,NA,HLT_0733,NA,HLGT_0408,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-04,2013-07-30,2013-08-03,23,27
CDISCPILOT01,AE,01-704-1325,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,2,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-16,2014-07-04,NA,73,NA
CDISCPILOT01,AE,01-704-1325,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,1,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-04,2014-05-23,NA,31,NA
CDISCPILOT01,AE,01-704-1332,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,4,E05,BURNING SENSATION,BURNING SENSATION,NA,BURNING SENSATION,NA,HLT_0775,NA,HLGT_0456,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-03,2014-02-03,NA,57,NA
CDISCPILOT01,AE,01-704-1332,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,2,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-20,2014-01-18,2014-02-24,41,78
CDISCPILOT01,AE,01-704-1332,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,6,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-24,2014-01-18,2014-02-24,41,78
CDISCPILOT01,AE,01-704-1332,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,1,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-23,2013-12-10,2014-02-24,2,78
CDISCPILOT01,AE,01-704-1332,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,3,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-03,2013-12-10,2014-02-24,2,78
CDISCPILOT01,AE,01-704-1332,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,5,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-24,2013-12-10,2014-02-24,2,78
CDISCPILOT01,AE,01-704-1351,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,2,E03,FLATULENCE,GAS,NA,FLATULENCE,NA,HLT_0356,NA,HLGT_0504,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-07,2013-10-27,2014-04-04,16,175
CDISCPILOT01,AE,01-704-1351,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,4,E03,FLATULENCE,GAS,NA,FLATULENCE,NA,HLT_0356,NA,HLGT_0504,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-18,2013-10-27,2014-04-04,16,175
CDISCPILOT01,AE,01-704-1351,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,1,E02,POLLAKIURIA,URINARY FREQUENCY,NA,POLLAKIURIA,NA,HLT_0393,NA,HLGT_0560,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-07,2013-10-27,2014-04-04,16,175
CDISCPILOT01,AE,01-704-1351,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,3,E02,POLLAKIURIA,URINARY FREQUENCY,NA,POLLAKIURIA,NA,HLT_0393,NA,HLGT_0560,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-18,2013-10-27,2014-04-04,16,175
CDISCPILOT01,AE,01-704-1388,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,1,E01,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-27,2012-08-23,NA,-10,NA
CDISCPILOT01,AE,01-704-1435,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,1,E08,PARKINSON'S DISEASE,DISEASE PARKINSON'S,NA,PARKINSON'S DISEASE,NA,HLT_0279,NA,HLGT_0313,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-12,2013-01-06,NA,51,NA
CDISCPILOT01,AE,01-704-1445,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,20,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,1,E06,COMPLETED SUICIDE,SUICIDE,NA,COMPLETED SUICIDE,NA,HLT_0625,NA,HLGT_0013,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,SEVERE,N,NA,NONE,FATAL,N,N,N,Y,N,N,N,2014-11-01,2014-10-31,2014-10-31,174,174
CDISCPILOT01,DM,01-705-1018,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-705-1031,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,1,E02,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-25,2013-12-25,NA,29,NA
CDISCPILOT01,AE,01-705-1059,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,1,E02,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-07,2013-11-02,NA,90,NA
CDISCPILOT01,AE,01-705-1186,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,1,E02,HYPERBILIRUBINAEMIA,HYPERBILIRUBINEMIA,NA,HYPERBILIRUBINAEMIA,NA,HLT_0478,NA,HLGT_0087,NA,HEPATOBILIARY DISORDERS,NA,HEPATOBILIARY DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-07,2014-01-26,NA,19,NA
CDISCPILOT01,AE,01-705-1199,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,1,E06,DYSPEPSIA,PYROSIS,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-29,2013-09-17,2013-09-29,2,14
CDISCPILOT01,AE,01-705-1199,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,2,E06,DYSPEPSIA,PYROSIS,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-29,2013-09-17,2013-09-29,2,14
CDISCPILOT01,AE,01-705-1280,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,1,E01,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-16,2014-04-20,NA,94,NA
CDISCPILOT01,AE,01-705-1281,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,2,E05,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-18,2014-01-30,NA,64,NA
CDISCPILOT01,AE,01-705-1281,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,1,E04,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-18,2014-01-30,NA,64,NA
CDISCPILOT01,AE,01-705-1281,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,3,E04,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-17,2014-01-30,NA,64,NA
CDISCPILOT01,DM,01-705-1282,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-705-1292,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,2,E02,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-03,2014-02-13,NA,123,NA
CDISCPILOT01,AE,01-705-1292,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,1,E01,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-29,2013-10-28,NA,15,NA
CDISCPILOT01,AE,01-705-1303,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,1,E02,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-10,2014-02-05,2014-03-03,52,78
CDISCPILOT01,AE,01-705-1303,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,3,E02,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-07,2014-02-05,2014-03-03,52,78
CDISCPILOT01,AE,01-705-1303,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,2,E03,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-10,2014-02-05,2014-03-03,52,78
CDISCPILOT01,AE,01-705-1303,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,4,E03,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-07,2014-02-05,2014-03-03,52,78
CDISCPILOT01,AE,01-705-1310,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,1,E02,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-22,2013-11-14,NA,13,NA
CDISCPILOT01,AE,01-705-1310,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,2,E03,WOUND HAEMORRHAGE,WOUND BLEEDING,NA,WOUND HAEMORRHAGE,NA,HLT_0154,NA,HLGT_0162,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-23,2014-01-09,NA,69,NA
CDISCPILOT01,AE,01-705-1349,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,4,E06,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-25,2013-08-25,NA,169,NA
CDISCPILOT01,AE,01-705-1349,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,1,E03,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-17,2013-04-08,2013-04-08,30,30
CDISCPILOT01,AE,01-705-1349,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,3,E05,VENTRICULAR HYPERTROPHY,LEFT VENTRICULAR HYPERTROPHY,NA,VENTRICULAR HYPERTROPHY,NA,HLT_0104,NA,HLGT_0259,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-25,2013-08-25,NA,169,NA
CDISCPILOT01,AE,01-705-1349,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,2,E04,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-17,2013-04-11,2013-04-11,33,33
CDISCPILOT01,DM,01-705-1377,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,DM,01-705-1382,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-705-1393,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,1,E01,ABDOMINAL PAIN,ABDOMINAL CRAMPS,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-27,2012-09-19,2012-09-24,13,18
CDISCPILOT01,AE,01-705-1393,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,3,E05,COLON CANCER,COLON CANCER,NA,COLON CANCER,NA,HLT_0597,NA,HLGT_0339,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,SEVERE,N,NA,NONE,RECOVERED/RESOLVED,Y,N,N,N,Y,N,N,2013-02-20,2013-01-21,2013-01-24,137,140
CDISCPILOT01,AE,01-705-1393,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,2,E04,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-05,2011-12-05,2013-02-20,-27,167
CDISCPILOT01,AE,01-705-1393,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,4,E04,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-25,2011-12-05,2013-02-20,-27,167
CDISCPILOT01,AE,01-705-1431,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,2,E04,ANXIETY,FEELING ANXIOUS,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-07,2013-07-04,2013-07-06,12,14
CDISCPILOT01,AE,01-705-1431,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,1,E05,RASH ERYTHEMATOUS,ERYTHEMATOUS RASH,NA,RASH ERYTHEMATOUS,NA,HLT_0336,NA,HLGT_0701,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-23,2013-06-22,NA,-1,NA
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,1,E02,ANXIETY,ANXIETY ATTACK,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-14,2012-05,NA,NA,NA
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,7,E02,ANXIETY,ANXIETY ATTACK,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-06,2012-05,NA,NA,NA
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,2,E01,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-14,2014-01-07,2014-01-08,8,9
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,3,E07,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-14,2014-01-14,2014-01-28,15,29
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,5,E07,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-30,2014-01-14,2014-01-28,15,29
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,4,E03,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-28,2014-01-15,2014-07-29,16,211
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,8,E03,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-29,2014-01-15,2014-07-29,16,211
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,6,E08,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-04,2014-03-04,2014-07-29,64,211
CDISCPILOT01,AE,01-706-1041,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,9,E08,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-29,2014-03-04,2014-07-29,64,211
CDISCPILOT01,AE,01-706-1049,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,1,E01,SYNCOPE,FAINTING,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-11,2013-06-03,2013-06-03,21,21
CDISCPILOT01,AE,01-706-1049,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,2,E02,SYNCOPE,SYNCOPAL ATTACK,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-06-25,2013-06-18,2013-06-18,36,36
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,1,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-15,2012-09-15,2012-09-29,1,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,6,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-22,2012-09-15,2012-09-29,1,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,4,E01,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-29,2012-09-23,2012-09-29,9,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,9,E01,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-22,2012-09-23,2012-09-29,9,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,3,E05,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-15,2012-09-15,2012-09-29,1,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,8,E05,EXCORIATION,ABRASIONS,NA,EXCORIATION,NA,HLT_0738,NA,HLGT_0511,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-22,2012-09-15,2012-09-29,1,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,2,E04,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-15,2012-09-15,2012-09-29,1,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,7,E04,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-22,2012-09-15,2012-09-29,1,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,5,E06,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-29,2012-09-23,2012-09-29,9,15
CDISCPILOT01,AE,01-706-1384,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,10,E06,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-22,2012-09-23,2012-09-29,9,15
CDISCPILOT01,DM,01-707-1037,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,2,E03,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,NA,BLOOD CREATINE PHOSPHOKINASE INCREASED,NA,HLT_0404,NA,HLGT_0008,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-27,2013-11-26,2013-12-09,30,43
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,4,E03,BLOOD CREATINE PHOSPHOKINASE INCREASED,CPK INCREASE,NA,BLOOD CREATINE PHOSPHOKINASE INCREASED,NA,HLT_0404,NA,HLGT_0008,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-23,2013-11-26,2013-12-09,30,43
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,7,E06,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-16,2014-02-08,2014-02-22,104,118
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,8,E06,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-16,2014-02-08,2014-02-22,104,118
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,3,E05,POSTNASAL DRIP,POSTNASAL DRIP,NA,POSTNASAL DRIP,NA,HLT_0172,NA,HLGT_0032,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-09,2013-12-03,2013-12-10,37,44
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,5,E05,POSTNASAL DRIP,POSTNASAL DRIP,NA,POSTNASAL DRIP,NA,HLT_0172,NA,HLGT_0032,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-23,2013-12-03,2013-12-10,37,44
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,1,E04,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,NA,SINUS ARRHYTHMIA,NA,HLT_0094,NA,HLGT_0630,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-25,2013-11-25,2013-12-23,29,57
CDISCPILOT01,AE,01-707-1206,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,6,E04,SINUS ARRHYTHMIA,SINUS ARRHYTHMIA,NA,SINUS ARRHYTHMIA,NA,HLT_0094,NA,HLGT_0630,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-19,2013-11-25,2013-12-23,29,57
CDISCPILOT01,AE,01-708-1019,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,5,E06,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-23,2014-01-01,2014-01-01,13,13
CDISCPILOT01,AE,01-708-1019,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,1,E02,HEADACHE,FRONTAL HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-23,2013-12-31,2013-12-31,12,12
CDISCPILOT01,AE,01-708-1019,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,2,E03,STUPOR,STUPOR,NA,STUPOR,NA,HLT_0595,NA,HLGT_0513,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-23,2014-01-01,2014-01-01,13,13
CDISCPILOT01,AE,01-708-1019,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,3,E04,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-23,2014-01-01,2014-01-01,13,13
CDISCPILOT01,AE,01-708-1019,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,4,E05,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-23,2014-01-01,2014-01-01,13,13
CDISCPILOT01,AE,01-708-1032,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,1,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-09,2013-02-26,2013-03-09,18,29
CDISCPILOT01,AE,01-708-1084,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,1,E02,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-23,2013-05-23,15,15
CDISCPILOT01,AE,01-708-1084,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,2,E02,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-09,2013-05-23,2013-05-23,15,15
CDISCPILOT01,AE,01-708-1084,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,3,E07,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-09,2013-06-09,2013-06-09,32,32
CDISCPILOT01,AE,01-708-1084,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,4,E07,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-11,2013-06-09,2013-06-09,32,32
CDISCPILOT01,AE,01-708-1084,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,5,E06,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-23,2013-06-23,2013-06-23,46,46
CDISCPILOT01,AE,01-708-1084,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,6,E06,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-07,2013-06-23,2013-06-23,46,46
CDISCPILOT01,AE,01-708-1087,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,3,E03,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-16,2013-02-04,2013-02-08,106,110
CDISCPILOT01,AE,01-708-1087,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,4,E02,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-16,2013-02-16,NA,118,NA
CDISCPILOT01,AE,01-708-1087,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,1,E05,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-19,2013-01-19,2013-01-19,90,90
CDISCPILOT01,AE,01-708-1087,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,2,E05,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-16,2013-01-19,2013-01-19,90,90
CDISCPILOT01,AE,01-708-1087,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,5,E06,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-16,2013-03-16,2013-03-16,146,146
CDISCPILOT01,AE,01-708-1087,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,6,E06,HEART RATE IRREGULAR,HEARTBEATS IRREGULAR,NA,HEART RATE IRREGULAR,NA,HLT_0765,NA,HLGT_0140,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-10,2013-03-16,2013-03-16,146,146
CDISCPILOT01,AE,01-708-1158,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,1,E05,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-26,2014-02-25,NA,18,NA
CDISCPILOT01,AE,01-708-1158,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,2,E07,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-22,2014-03-22,2014-03-22,43,43
CDISCPILOT01,DM,01-708-1171,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,9,E13,ALCOHOL USE,ALCOHOL USE,NA,ALCOHOL USE,NA,HLT_0138,NA,HLGT_0182,NA,SOCIAL CIRCUMSTANCES,NA,SOCIAL CIRCUMSTANCES,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-06,2014-03-24,2014-03-24,86,86
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,3,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-09,2014-03-09,2014-04-06,71,99
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,5,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-06,2014-03-09,2014-04-06,71,99
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,7,E10,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,SEVERE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2014-04-06,2014-03-24,2014-03-26,86,88
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,8,E11,CYSTITIS,BLADDER INFECTION,NA,CYSTITIS,NA,HLT_0739,NA,HLGT_0129,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-06,2014-03-24,2014-03-28,86,90
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,6,E09,DIZZINESS,LIGHT-HEADED,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2014-04-06,2014-03-24,2014-03-26,86,88
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,1,E03,FLANK PAIN,FLANK PAIN,NA,FLANK PAIN,NA,HLT_0484,NA,HLGT_0543,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-19,2013-12-19,NA,-10,NA
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,2,E05,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-09,2014-03-01,2014-03-08,63,70
CDISCPILOT01,AE,01-708-1178,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,4,E08,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,NA,VENTRICULAR SEPTAL DEFECT,NA,HLT_0589,NA,HLGT_0747,NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-09,2014-03-09,NA,71,NA
CDISCPILOT01,AE,01-708-1213,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,1,E03,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-22,2013-02-22,2013-02-22,14,14
CDISCPILOT01,AE,01-708-1213,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,2,E03,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-26,2013-02-22,2013-02-22,14,14
CDISCPILOT01,AE,01-708-1216,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,2,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-08,2012-11-06,2012-12-13,14,51
CDISCPILOT01,AE,01-708-1216,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,4,E05,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-09,2012-11-06,2012-12-13,14,51
CDISCPILOT01,AE,01-708-1216,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,1,E01,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-08,2012-11-06,NA,14,NA
CDISCPILOT01,AE,01-708-1216,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,3,E02,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-22,2012-11-22,NA,30,NA
CDISCPILOT01,DM,01-708-1236,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,2,E04,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-07,2013-05-06,2013-05-16,-1,10
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,5,E04,CONJUNCTIVITIS,CONJUNCTIVITIS,NA,CONJUNCTIVITIS,NA,HLT_0584,NA,HLGT_0335,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-21,2013-05-06,2013-05-16,-1,10
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,1,E03,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-07,2013-05-06,2013-05-16,-1,10
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,4,E03,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-21,2013-05-06,2013-05-16,-1,10
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,7,E05,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-07,2013-06-07,2013-06-07,32,32
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,8,E05,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-09,2013-06-07,2013-06-07,32,32
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,3,E02,HEART RATE INCREASED,HEART RATE INCREASED,NA,HEART RATE INCREASED,NA,HLT_0646,NA,HLGT_0673,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-07,2013-05-07,2013-05-10,1,4
CDISCPILOT01,AE,01-708-1253,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,6,E02,HEART RATE INCREASED,HEART RATE INCREASED,NA,HEART RATE INCREASED,NA,HLT_0646,NA,HLGT_0673,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-21,2013-05-07,2013-05-10,1,4
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,4,E11,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-07,2013-02-27,2013-02-27,22,22
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,5,E08,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-07,2013-03-01,2013-03-07,24,30
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,8,E08,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-09,2013-03-01,2013-03-07,24,30
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,1,E12,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-21,2013-02-11,2013-02-11,6,6
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,7,E10,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-07,2013-03-07,2013-03-07,30,30
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,10,E10,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-09,2013-03-07,2013-03-07,30,30
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,11,E14,HOT FLUSH,HOT FLASHES,NA,HOT FLUSH,NA,HLT_0737,NA,HLGT_0773,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-20,2013-03-19,2013-03-19,42,42
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,2,E13,MUSCLE SPASMS,LEG CRAMPS,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,SEVERE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-21,2013-02-18,2013-02-18,13,13
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,6,E09,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-07,2013-03-01,2013-03-07,24,30
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,9,E09,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-09,2013-03-01,2013-03-07,24,30
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,3,E05,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-21,2013-02-21,2013-03-20,16,43
CDISCPILOT01,AE,01-708-1272,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,12,E05,VENTRICULAR EXTRASYSTOLES,VENTRICULAR BIGEMINY,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-04,2013-02-21,2013-03-20,16,43
CDISCPILOT01,AE,01-708-1286,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,3,E08,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-23,2014-02-18,2014-02-18,162,162
CDISCPILOT01,AE,01-708-1286,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,1,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-23,2013-09-12,NA,3,NA
CDISCPILOT01,AE,01-708-1286,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,4,E09,CONSTIPATION,CONSTIPATION,NA,CONSTIPATION,NA,HLT_0402,NA,HLGT_0635,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-23,2014-02-18,2014-02-18,162,162
CDISCPILOT01,AE,01-708-1286,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,2,E04,MYOCARDIAL INFARCTION,INFERIOR MYOCARDIAL INFARCTIO,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-23,2013-09-23,NA,14,NA
CDISCPILOT01,AE,01-708-1296,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,3,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-04,2013-09-04,2013-09-18,83,97
CDISCPILOT01,AE,01-708-1296,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,4,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-02,2013-09-04,2013-09-18,83,97
CDISCPILOT01,AE,01-708-1296,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,5,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-30,2013-10-04,2013-10-30,113,139
CDISCPILOT01,AE,01-708-1296,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,6,E05,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-27,2013-10-04,2013-10-30,113,139
CDISCPILOT01,AE,01-708-1296,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,1,E03,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,NA,ATRIAL HYPERTROPHY,NA,HLT_0271,NA,HLGT_0067,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-27,2013-06-27,2013-06-27,14,14
CDISCPILOT01,AE,01-708-1296,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,2,E03,ATRIAL HYPERTROPHY,LEFT ATRIAL HYPERTROPHY,NA,ATRIAL HYPERTROPHY,NA,HLT_0271,NA,HLGT_0067,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-10,2013-06-27,2013-06-27,14,14
CDISCPILOT01,AE,01-708-1296,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,7,E07,PAIN IN EXTREMITY,PAIN IN THIGH,NA,PAIN IN EXTREMITY,NA,HLT_0213,NA,HLGT_0764,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-12,2013-12-07,2013-12-07,177,177
CDISCPILOT01,AE,01-708-1297,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,1,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-16,2013-04-02,NA,68,NA
CDISCPILOT01,AE,01-708-1297,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,2,E03,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-16,2013-04-02,NA,68,NA
CDISCPILOT01,AE,01-708-1297,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,3,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-08,2013-05-08,NA,104,NA
CDISCPILOT01,AE,01-708-1316,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,2,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-15,2014-02-15,NA,177,NA
CDISCPILOT01,AE,01-708-1316,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,1,E05,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-15,2014-01-29,NA,160,NA
CDISCPILOT01,AE,01-708-1336,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,5,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-23,2013-04-10,2013-06-05,125,181
CDISCPILOT01,AE,01-708-1336,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,7,E11,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-05,2013-04-10,2013-06-05,125,181
CDISCPILOT01,AE,01-708-1336,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,2,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-15,2013-01-12,2013-01-12,37,37
CDISCPILOT01,AE,01-708-1336,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,4,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-23,2013-04-10,2013-06-05,125,181
CDISCPILOT01,AE,01-708-1336,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,6,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-05,2013-04-10,2013-06-05,125,181
CDISCPILOT01,AE,01-708-1336,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,1,E06,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-21,2012-12-18,2012-12-18,12,12
CDISCPILOT01,AE,01-708-1336,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,3,E09,DIZZINESS,LIGHT HEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-27,2013-02-02,2013-02-02,58,58
CDISCPILOT01,DM,01-708-1342,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,3,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,7,E04,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-02,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,4,E05,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,8,E05,APPLICATION SITE SWELLING,APPLICATION SITE SWELLING,NA,APPLICATION SITE SWELLING,NA,HLT_0105,NA,HLGT_0236,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-02,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,2,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,6,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-02,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,1,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1347,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,5,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-02,2013-06-13,2013-06-25,55,67
CDISCPILOT01,AE,01-708-1348,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,3,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-01,2013-12-01,NA,119,NA
CDISCPILOT01,AE,01-708-1348,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,1,E04,MYOCARDIAL INFARCTION,ANTEROSEPTAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-19,2013-08-18,2013-08-31,14,27
CDISCPILOT01,AE,01-708-1348,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,2,E04,MYOCARDIAL INFARCTION,ANTEROSEPTAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-02,2013-08-18,2013-08-31,14,27
CDISCPILOT01,AE,01-708-1353,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,1,E09,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-18,2013-08-18,2013-09-10,46,69
CDISCPILOT01,AE,01-708-1353,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,2,E09,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-10,2013-08-18,2013-09-10,46,69
CDISCPILOT01,AE,01-708-1353,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,3,E10,HYPOTENSION,LOW BLOOD PRESSURE,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-10,2013-08-28,2013-09-10,56,69
CDISCPILOT01,AE,01-708-1372,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,1,E03,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-10,2013-04-10,NA,-2,NA
CDISCPILOT01,DM,01-708-1378,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-708-1406,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,1,E03,OEDEMA PERIPHERAL,SWELLING OF LEGS,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-16,2014-06-16,NA,173,NA
CDISCPILOT01,AE,01-708-1406,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,2,E04,OEDEMA PERIPHERAL,SWELLING OF LEGS,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-16,2014-06-16,NA,173,NA
CDISCPILOT01,AE,01-708-1428,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,3,E02,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-10,2013-12-10,2013-12-21,32,43
CDISCPILOT01,AE,01-708-1428,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,6,E02,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-26,2013-12-10,2013-12-21,32,43
CDISCPILOT01,AE,01-708-1428,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,2,E01,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-10,2013-12-10,2013-12-21,32,43
CDISCPILOT01,AE,01-708-1428,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,5,E01,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-26,2013-12-10,2013-12-21,32,43
CDISCPILOT01,AE,01-708-1428,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,4,E03,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,NA,APPLICATION SITE WARMTH,NA,HLT_0260,NA,HLGT_0301,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-10,2013-12-10,2013-12-21,32,43
CDISCPILOT01,AE,01-708-1428,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,7,E03,APPLICATION SITE WARMTH,APPLICATION SITE WARMTH,NA,APPLICATION SITE WARMTH,NA,HLT_0260,NA,HLGT_0301,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-26,2013-12-10,2013-12-21,32,43
CDISCPILOT01,AE,01-708-1428,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,1,E04,EPISTAXIS,NOSE BLEED,NA,EPISTAXIS,NA,HLT_0386,NA,HLGT_0577,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-23,2013-11-22,2013-11-22,14,14
CDISCPILOT01,DM,01-709-1001,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-709-1007,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,1,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-18,2012-08-16,2012-08-19,17,20
CDISCPILOT01,AE,01-709-1007,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,2,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-01,2012-08-16,2012-08-19,17,20
CDISCPILOT01,AE,01-709-1007,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,3,E03,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-09-01,2012-08-21,NA,22,NA
CDISCPILOT01,AE,01-709-1007,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,4,E04,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-01,2012-08-30,2012-08-30,31,31
CDISCPILOT01,AE,01-709-1020,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,3,E03,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-12,2013-01-03,2013-01-11,34,42
CDISCPILOT01,AE,01-709-1020,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,1,E01,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-27,2012-12-27,NA,27,NA
CDISCPILOT01,AE,01-709-1020,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,4,E04,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-26,2013-01-15,NA,46,NA
CDISCPILOT01,AE,01-709-1020,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,2,E02,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-12,2013-01-03,2013-01-11,34,42
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,2,E08,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-21,2013-01-17,NA,24,NA
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,10,E11,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-15,2013-05-12,2013-05-19,139,146
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,13,E11,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-12,2013-05-12,2013-05-19,139,146
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,3,E07,MUSCLE SPASMS,CRAMP,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-06,2013-01-24,2013-02-27,31,65
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,5,E07,MUSCLE SPASMS,CRAMP,NA,MUSCLE SPASMS,NA,HLT_0078,NA,HLGT_0750,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-20,2013-01-24,2013-02-27,31,65
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,1,E09,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-09,2013-01-09,2013-02-19,16,57
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,4,E09,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-20,2013-01-09,2013-02-19,16,57
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,6,E10,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-20,2013-03-20,2013-04-16,86,113
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,8,E10,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-15,2013-03-20,2013-04-16,86,113
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,12,E13,MYOCARDIAL INFARCTION,SEPTAL MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-15,2013-05-15,NA,142,NA
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,11,E12,PHARYNGEAL ERYTHEMA,RED THROAT,NA,PHARYNGEAL ERYTHEMA,NA,HLT_0591,NA,HLGT_0398,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-15,2013-05-12,2013-05-19,139,146
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,14,E12,PHARYNGEAL ERYTHEMA,RED THROAT,NA,PHARYNGEAL ERYTHEMA,NA,HLT_0591,NA,HLGT_0398,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-12,2013-05-12,2013-05-19,139,146
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,16,E14,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-26,2013-06-19,NA,177,NA
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,7,E15,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-20,2013-03-20,2013-04-16,86,113
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,9,E15,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-15,2013-03-20,2013-04-16,86,113
CDISCPILOT01,AE,01-709-1029,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,15,E16,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-12,2013-06-12,NA,170,NA
CDISCPILOT01,AE,01-709-1081,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,2,E06,OEDEMA PERIPHERAL,PERIPHERAL SWELLING,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-10,2014-05-01,NA,104,NA
CDISCPILOT01,AE,01-709-1081,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,1,E05,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-21,2014-04-07,NA,80,NA
CDISCPILOT01,AE,01-709-1088,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,1,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-08,2014-05-08,NA,27,NA
CDISCPILOT01,AE,01-709-1088,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,2,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-08-02,2014-08-02,NA,113,NA
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,8,E06,ACROCHORDON EXCISION,SKIN TAG REMOVAL,NA,ACROCHORDON EXCISION,NA,HLT_0629,NA,HLGT_0103,NA,SURGICAL AND MEDICAL PROCEDURES,NA,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-11,2014-03-23,2014-03-23,150,150
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,2,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-12,2013-11-12,NA,19,NA
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,6,E02,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-26,2013-11-12,NA,19,NA
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,4,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-12,2013-11-12,NA,19,NA
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,7,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-26,2013-11-12,NA,19,NA
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,3,E04,APPLICATION SITE VESICLES,APPLICATION SITE VESICLES,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-12,2013-11-12,NA,19,NA
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,1,E01,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-12,2013-11-06,2013-11-17,13,24
CDISCPILOT01,AE,01-709-1099,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,5,E01,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-27,2013-11-06,2013-11-17,13,24
CDISCPILOT01,AE,01-709-1102,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,1,E01,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-11,2013-02-11,NA,28,NA
CDISCPILOT01,AE,01-709-1102,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,3,E01,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-12,2013-02-11,NA,28,NA
CDISCPILOT01,AE,01-709-1102,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,2,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-11,2013-02-11,NA,28,NA
CDISCPILOT01,AE,01-709-1102,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,4,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-12,2013-02-11,NA,28,NA
CDISCPILOT01,AE,01-709-1102,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,6,E04,APPLICATION SITE VESICLES,APPLICATION SITE BLISTER,NA,APPLICATION SITE VESICLES,NA,HLT_0180,NA,HLGT_0576,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-31,2013-03-26,2013-03-27,71,72
CDISCPILOT01,AE,01-709-1102,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,5,E05,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-31,2013-03-20,2013-03-26,65,71
CDISCPILOT01,AE,01-709-1168,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,3,E03,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-13,2013-09-06,2013-10-11,36,71
CDISCPILOT01,AE,01-709-1168,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,5,E03,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-01,2013-09-06,2013-10-11,36,71
CDISCPILOT01,AE,01-709-1168,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,4,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-13,2013-09-06,2013-10-11,36,71
CDISCPILOT01,AE,01-709-1168,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,6,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-01,2013-09-06,2013-10-11,36,71
CDISCPILOT01,AE,01-709-1168,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,1,E02,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-17,2013-08-17,2013-09-06,16,36
CDISCPILOT01,AE,01-709-1168,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,2,E02,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-13,2013-08-17,2013-09-06,16,36
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,3,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-26,2013-06-18,23,107
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,8,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-29,2013-03-26,2013-06-18,23,107
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,10,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-25,2013-03-26,2013-06-18,23,107
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,2,E06,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-20,NA,17,NA
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,1,E09,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-19,2013-03-06,2013-03-06,3,3
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,4,E07,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-27,2013-03-27,24,24
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,6,E08,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-01,2013-04-01,2013-04-11,29,39
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,7,E08,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-13,2013-04-01,2013-04-11,29,39
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,5,E13,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-30,NA,27,NA
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,9,E14,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-25,2013-05-17,2013-05-18,75,76
CDISCPILOT01,AE,01-709-1217,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,11,E10,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-25,2013-05-27,2013-06-18,85,107
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,2,E07,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-05-30,NA,16,NA
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,4,E09,APPLICATION SITE DISCHARGE,APPLICATION SITE DISCHARGE,NA,APPLICATION SITE DISCHARGE,NA,HLT_0200,NA,HLGT_0457,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-05-30,NA,16,NA
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,3,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-05-30,NA,16,NA
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,6,E04,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-06-09,NA,26,NA
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,1,E02,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-29,2013-05-28,2013-05-28,14,14
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,5,E05,HIP FRACTURE,HIP FRACTURE,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-05-31,2013-05-31,17,17
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,8,E10,SKIN LESION EXCISION,SKIN LESION EXCISION,NA,SKIN LESION EXCISION,NA,HLT_0498,NA,HLGT_0450,NA,SURGICAL AND MEDICAL PROCEDURES,NA,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-02,2013-06-28,2013-06-28,45,45
CDISCPILOT01,AE,01-709-1238,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,7,E06,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-06-09,NA,26,NA
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,5,E08,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,2013-03-23,2013-03-17,2013-03-30,51,64
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,6,E08,BENIGN PROSTATIC HYPERPLASIA,ENLARGED PROSTATE,NA,BENIGN PROSTATIC HYPERPLASIA,NA,HLT_0215,NA,HLGT_0568,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,SEVERE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-04-20,2013-03-17,2013-03-30,51,64
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,3,E06,BLOOD URINE PRESENT,BLOOD IN URINE,NA,BLOOD URINE PRESENT,NA,HLT_0458,NA,HLGT_0289,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-23,2013-03-14,NA,48,NA
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,4,E07,CYSTOSCOPY,CYSTOSCOPY,NA,CYSTOSCOPY,NA,HLT_0436,NA,HLGT_0041,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-23,2013-03-17,2013-03-17,51,51
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,8,E12,DEHYDRATION,DEHYDRATION,NA,DEHYDRATION,NA,HLT_0533,NA,HLGT_0011,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-20,2013-04-13,2013-04-14,78,79
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,9,E13,HYPOTENSION,LOW BLOOD PRESSURE,NA,HYPOTENSION,NA,HLT_0761,NA,HLGT_0412,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-04-20,2013-04-13,2013-04-14,78,79
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,1,E05,LOCALISED INFECTION,INFECTED FINGER,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-10,2013-02-05,2013-02-13,11,19
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,2,E05,LOCALISED INFECTION,INFECTED FINGER,NA,LOCALISED INFECTION,NA,HLT_0435,NA,HLGT_0557,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-22,2013-02-05,2013-02-13,11,19
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,10,E14,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,NA,ORTHOSTATIC HYPOTENSION,NA,HLT_0194,NA,HLGT_0111,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-20,2013-04-20,2013-06-13,85,139
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,11,E14,ORTHOSTATIC HYPOTENSION,POSTURAL HYPOTENSION,NA,ORTHOSTATIC HYPOTENSION,NA,HLT_0194,NA,HLGT_0111,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-04-20,2013-06-13,85,139
CDISCPILOT01,AE,01-709-1259,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,7,E11,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-20,2013-04-13,2013-04-14,78,79
CDISCPILOT01,AE,01-709-1285,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,2,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-19,2013-04-19,2013-05-31,27,69
CDISCPILOT01,AE,01-709-1285,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,5,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-31,2013-04-19,2013-05-31,27,69
CDISCPILOT01,AE,01-709-1285,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,3,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-19,2013-04-19,2013-05-31,27,69
CDISCPILOT01,AE,01-709-1285,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,6,E05,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-31,2013-04-19,2013-05-31,27,69
CDISCPILOT01,AE,01-709-1285,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,1,E03,HEMIANOPIA HOMONYMOUS,HOMONYMOUS HEMIANOPSIA,NA,HEMIANOPIA HOMONYMOUS,NA,HLT_0639,NA,HLGT_0547,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,Y,N,N,N,N,2013-04-19,2013-04-14,NA,22,NA
CDISCPILOT01,AE,01-709-1285,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,4,E06,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-19,2013-05-19,NA,57,NA
CDISCPILOT01,AE,01-709-1301,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,1,E02,DIABETES MELLITUS,DIABETES,NA,DIABETES MELLITUS,NA,HLT_0447,NA,HLGT_0572,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-30,2013-08-30,NA,43,NA
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,5,E03,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-28,2014-05-04,2014-06-23,91,141
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,9,E03,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-25,2014-05-04,2014-06-23,91,141
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,2,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-30,2014-04-20,2014-06-23,77,141
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,4,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-28,2014-04-20,2014-06-23,77,141
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,8,E02,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-25,2014-04-20,2014-06-23,77,141
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,6,E04,DRUG ERUPTION,DRUG RASH,NA,DRUG ERUPTION,NA,HLT_0430,NA,HLGT_0253,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-05-28,2014-05-20,2014-05-23,107,110
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,1,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-30,2014-04-20,2014-06-23,77,141
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,3,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-28,2014-04-20,2014-06-23,77,141
CDISCPILOT01,AE,01-709-1306,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,7,E01,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-25,2014-04-20,2014-06-23,77,141
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,12,E10,ALLERGIC GRANULOMATOUS ANGIITIS,ALLERGIC GRANULOMATOSIS,NA,ALLERGIC GRANULOMATOUS ANGIITIS,NA,HLT_0114,NA,HLGT_0157,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-16,2013-07-04,2013-07-04,16,16
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,14,E12,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-07-28,NA,40,NA
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,8,E09,BIOPSY,BIOPSY,NA,BIOPSY,NA,HLT_0685,NA,HLGT_0076,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-01,2013-06-26,2013-06-26,8,8
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,9,E08,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-01,2013-07-01,2013-07-01,13,13
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,11,E08,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-16,2013-07-01,2013-07-01,13,13
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,15,E13,FEELING COLD,FEELING COLD,NA,FEELING COLD,NA,HLT_0340,NA,HLGT_0717,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-11,2013-09-06,NA,80,NA
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,5,E06,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-01,2013-06-19,2013-06-20,1,2
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,6,E07,NIGHTMARE,NIGHTMARE,NA,NIGHTMARE,NA,HLT_0186,NA,HLGT_0049,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-01,2013-06-19,2013-06-20,1,2
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,1,E02,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-17,2013-06-10,2013-07-01,-9,13
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,10,E02,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-16,2013-06-10,2013-07-01,-9,13
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,7,E04,RASH MACULO-PAPULAR,MACULOPAPULAR RASH,NA,RASH MACULO-PAPULAR,NA,HLT_0500,NA,HLGT_0097,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-01,2013-06-20,NA,2,NA
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,2,E03,RASH PAPULAR,PAPULAR RASH,NA,RASH PAPULAR,NA,HLT_0549,NA,HLGT_0007,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-06-18,2013-07-16,-1,28
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,13,E03,RASH PAPULAR,PAPULAR RASH,NA,RASH PAPULAR,NA,HLT_0549,NA,HLGT_0007,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-18,2013-06-18,2013-07-16,-1,28
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,3,E05,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-06-19,2013-06-19,1,1
CDISCPILOT01,AE,01-709-1309,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,4,E05,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-01,2013-06-19,2013-06-19,1,1
CDISCPILOT01,AE,01-709-1312,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,1,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-17,2014-05-17,NA,28,NA
CDISCPILOT01,AE,01-709-1312,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,2,E05,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-10-19,2014-10-19,NA,183,NA
CDISCPILOT01,AE,01-709-1326,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,5,E07,APPLICATION SITE BLEEDING,APPLICATION SITE BLEEDING,NA,APPLICATION SITE BLEEDING,NA,HLT_0718,NA,HLGT_0324,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-26,2013-06-07,2013-06-17,64,74
CDISCPILOT01,AE,01-709-1326,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,1,E05,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-01,2013-05-01,NA,27,NA
CDISCPILOT01,AE,01-709-1326,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,2,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-01,2013-05-01,NA,27,NA
CDISCPILOT01,AE,01-709-1326,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,6,E08,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-26,2013-07-12,NA,99,NA
CDISCPILOT01,AE,01-709-1326,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,4,E04,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-06-01,2013-05-21,2013-05-21,47,47
CDISCPILOT01,AE,01-709-1326,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,3,E03,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-01,2013-05-21,2013-05-21,47,47
CDISCPILOT01,AE,01-709-1329,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,1,E02,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-29,2013-08-25,2013-08-25,11,11
CDISCPILOT01,AE,01-709-1329,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,2,E03,PYREXIA,FEVER,NA,PYREXIA,NA,HLT_0310,NA,HLGT_0652,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-29,2013-08-25,2013-08-25,11,11
CDISCPILOT01,AE,01-709-1339,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,2,E05,BLOOD ALKALINE PHOSPHATASE INCREASED,ALK PHOS RAISED,NA,BLOOD ALKALINE PHOSPHATASE INCREASED,NA,HLT_0615,NA,HLGT_0298,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-12,2013-05-12,NA,141,NA
CDISCPILOT01,AE,01-709-1339,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,1,E04,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-19,2011-11,NA,NA,NA
CDISCPILOT01,AE,01-709-1424,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,1,E05,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,Y,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,Y,N,2013-03-08,2013-03-07,2013-03-07,5,5
CDISCPILOT01,AE,01-710-1002,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,1,E01,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,2014-01-18,2014-01-16,2014-01-20,3,7
CDISCPILOT01,AE,01-710-1002,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,2,E01,TRANSIENT ISCHAEMIC ATTACK,TRANSIENT ISCHEMIC ATTACKS,NA,TRANSIENT ISCHAEMIC ATTACK,NA,HLT_0041,NA,HLGT_0433,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2014-01-20,2014-01-16,2014-01-20,3,7
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,12,E11,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-10,2013-08-08,NA,180,NA
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,1,E01,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-22,2013-02-18,2013-02-19,9,10
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,4,E05,DIZZINESS,FELT FAINT,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-04,2013-04-16,2013-04-16,66,66
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,11,E10,FACIAL BONES FRACTURE,FRACTURED NOSE,NA,FACIAL BONES FRACTURE,NA,HLT_0305,NA,HLGT_0585,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-10,2013-08-08,NA,180,NA
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,10,E09,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-10,2013-08-08,2013-08-08,180,180
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,6,E06,NEPHROLITHIASIS,KIDNEY STONE,NA,NEPHROLITHIASIS,NA,HLT_0439,NA,HLGT_0546,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-04,2013-04-17,2013-04-17,67,67
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,7,E07,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-01,2013-05-18,NA,98,NA
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,2,E02,SALIVARY HYPERSECRETION,SALIVATION,NA,SALIVARY HYPERSECRETION,NA,HLT_0374,NA,HLGT_0488,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-08,2013-03-01,NA,20,NA
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,8,E08,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-29,2013-06-29,2013-07-04,140,145
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,9,E08,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-27,2013-06-29,2013-07-04,140,145
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,3,E03,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-08,2013-03-01,NA,20,NA
CDISCPILOT01,AE,01-710-1006,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,5,E04,URINARY TRACT INFECTION,URINARY INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-04,2013-04-17,2013-04-19,67,69
CDISCPILOT01,AE,01-710-1021,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,1,E01,CHEST PAIN,CHEST PAIN,NA,CHEST PAIN,NA,HLT_0717,NA,HLGT_0195,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-11,2013-10-10,2013-10-10,14,14
CDISCPILOT01,AE,01-710-1021,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,2,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-27,2013-10-21,2013-10-31,25,35
CDISCPILOT01,AE,01-710-1021,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,3,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-12,2013-10-21,2013-10-31,25,35
CDISCPILOT01,AE,01-710-1027,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,1,E05,HAEMOPTYSIS,COUGHING BLOOD,NA,HAEMOPTYSIS,NA,HLT_0192,NA,HLGT_0680,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-23,2014-05-09,2014-06-01,71,94
CDISCPILOT01,AE,01-710-1027,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,3,E05,HAEMOPTYSIS,COUGHING BLOOD,NA,HAEMOPTYSIS,NA,HLT_0192,NA,HLGT_0680,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-20,2014-05-09,2014-06-01,71,94
CDISCPILOT01,AE,01-710-1027,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,2,E06,RALES,RALES,NA,RALES,NA,HLT_0020,NA,HLGT_0410,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-23,2014-05-23,2014-06-20,85,113
CDISCPILOT01,AE,01-710-1027,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,4,E06,RALES,RALES,NA,RALES,NA,HLT_0020,NA,HLGT_0410,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-17,2014-05-23,2014-06-20,85,113
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,7,E10,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-17,2013-08-03,2013-08-17,62,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,12,E10,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-08,2013-08-03,2013-08-17,62,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,2,E06,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-05,2013-07-02,2013-07-09,30,37
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,5,E06,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-15,2013-07-02,2013-07-09,30,37
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,4,E08,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-05,2013-07-02,2013-08-17,30,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,10,E08,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-08,2013-07-02,2013-08-17,30,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,6,E09,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-29,2013-07-22,2013-08-17,50,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,11,E09,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-08,2013-07-22,2013-08-17,50,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,8,E11,SKIN EXFOLIATION,SKIN PEELING,NA,SKIN EXFOLIATION,NA,HLT_0236,NA,HLGT_0726,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-17,2013-08-13,2013-08-17,72,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,13,E11,SKIN EXFOLIATION,SKIN PEELING,NA,SKIN EXFOLIATION,NA,HLT_0236,NA,HLGT_0726,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-08,2013-08-13,2013-08-17,72,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,3,E07,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-05,2013-07-02,2013-08-17,30,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,9,E07,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-08,2013-07-02,2013-08-17,30,76
CDISCPILOT01,AE,01-710-1045,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,1,E05,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-01,2013-06-22,2013-06-22,20,20
CDISCPILOT01,AE,01-710-1053,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,1,E03,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-06,2013-01-28,2013-02-11,34,48
CDISCPILOT01,AE,01-710-1053,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,3,E03,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-15,2013-01-28,2013-02-11,34,48
CDISCPILOT01,AE,01-710-1053,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,2,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-06,2013-01-28,2013-02-11,34,48
CDISCPILOT01,AE,01-710-1053,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,4,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-15,2013-01-28,2013-02-11,34,48
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,4,E07,APPLICATION SITE INDURATION,APPLICATION SITE INDURATION,NA,APPLICATION SITE INDURATION,NA,HLT_0696,NA,HLGT_0715,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-01,2013-01-21,2013-01-21,21,21
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,5,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-01,2013-01-23,2013-01-23,23,23
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,6,E08,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-01,2013-01-31,2013-01-31,31,31
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,7,E09,FALL,FALLING DOWN,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-12,2013-02-08,2013-02-08,39,39
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,8,E10,FALL,FALLING DOWN,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-12,2013-02-09,2013-02-09,40,40
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,2,E04,INSOMNIA,DIFFICULTY SLEEPING,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-15,2013-01-04,2013-01-15,4,15
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,3,E04,INSOMNIA,DIFFICULTY SLEEPING,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-01,2013-01-04,2013-01-15,4,15
CDISCPILOT01,AE,01-710-1060,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,1,E05,NASAL CONGESTION,NASAL CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-15,2013-01-02,2013-01-02,2,2
CDISCPILOT01,AE,01-710-1070,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,3,E10,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-28,2012-12-12,NA,96,NA
CDISCPILOT01,AE,01-710-1070,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,6,E13,GASTROINTESTINAL HAEMORRHAGE,GI BLEED,NA,GASTROINTESTINAL HAEMORRHAGE,NA,HLT_0354,NA,HLGT_0020,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,SEVERE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-02-23,2013-02-05,2013-02-10,151,156
CDISCPILOT01,AE,01-710-1070,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,5,E12,HIP FRACTURE,HIP FRACTURE,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-02-23,2013-01-22,2013-01-25,137,140
CDISCPILOT01,AE,01-710-1070,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,2,E09,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-28,2012-12-12,NA,96,NA
CDISCPILOT01,AE,01-710-1070,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,4,E11,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-28,2012-12-12,NA,96,NA
CDISCPILOT01,AE,01-710-1070,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,1,E08,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-06,2012-10-06,NA,29,NA
CDISCPILOT01,AE,01-710-1077,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,3,E06,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-12,2014-01-12,NA,57,NA
CDISCPILOT01,AE,01-710-1077,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,1,E04,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-15,2013-12-12,2013-12-12,26,26
CDISCPILOT01,AE,01-710-1077,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,4,E01,ARTHRITIS,ARTHRITIS,NA,ARTHRITIS,NA,HLT_0019,NA,HLGT_0587,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,SEVERE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-06,1977,NA,NA,NA
CDISCPILOT01,AE,01-710-1077,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,5,E01,ARTHRITIS,ARTHRITIS,NA,ARTHRITIS,NA,HLT_0019,NA,HLGT_0587,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-03,1977,NA,NA,NA
CDISCPILOT01,AE,01-710-1077,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,2,E05,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-12-30,2013-12-27,NA,41,NA
CDISCPILOT01,DM,01-710-1078,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-710-1083,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,20,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,1,E04,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCT,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,SEVERE,N,NA,POSSIBLE,FATAL,N,N,N,Y,Y,Y,N,2013-08-03,2013-08-02,2013-08-02,12,12
CDISCPILOT01,AE,01-710-1137,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,2,E05,ERYTHEMA,REDNESS,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-25,2013-10-13,NA,3,NA
CDISCPILOT01,AE,01-710-1137,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,4,E07,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-13,2013-11-13,NA,34,NA
CDISCPILOT01,AE,01-710-1137,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,1,E04,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-25,2013-10-13,NA,3,NA
CDISCPILOT01,AE,01-710-1137,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,3,E06,VERTIGO,VERTIGO,NA,VERTIGO,NA,HLT_0255,NA,HLGT_0147,NA,EAR AND LABYRINTH DISORDERS,NA,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-08,2013-11-04,NA,25,NA
CDISCPILOT01,AE,01-710-1142,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,1,E02,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-16,2012-10-04,2012-10-06,3,5
CDISCPILOT01,AE,01-710-1142,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,2,E03,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-16,2012-10-04,2012-10-06,3,5
CDISCPILOT01,AE,01-710-1142,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,4,E05,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCTION,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2012-10-23,2012-10-19,2012-10-19,18,18
CDISCPILOT01,AE,01-710-1142,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,3,E07,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-16,2012-10-14,2012-10-14,13,13
CDISCPILOT01,AE,01-710-1142,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,5,E06,SYNCOPE VASOVAGAL,SYNCOPE VASOVAGAL,NA,SYNCOPE VASOVAGAL,NA,HLT_0003,NA,HLGT_0687,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-10-23,2012-10-19,2012-10-19,18,18
CDISCPILOT01,AE,01-710-1154,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,1,E04,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-25,2014-04-18,NA,21,NA
CDISCPILOT01,AE,01-710-1154,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,2,E04,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-09,2014-04-18,NA,21,NA
CDISCPILOT01,AE,01-710-1166,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,4,E09,COMPLEX PARTIAL SEIZURES,COMPLEX PARTIAL SEIZURES,NA,COMPLEX PARTIAL SEIZURES,NA,HLT_0558,NA,HLGT_0656,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-03-30,2013-03-19,2013-03-20,110,111
CDISCPILOT01,AE,01-710-1166,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,1,E05,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-19,2013-03-19,110,110
CDISCPILOT01,AE,01-710-1166,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,2,E06,SKIN LACERATION,LACERATION OF HEAD,NA,SKIN LACERATION,NA,HLT_0075,NA,HLGT_0118,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-19,2013-03-19,110,110
CDISCPILOT01,AE,01-710-1166,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,3,E07,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-30,2013-03-19,2013-03-19,110,110
CDISCPILOT01,AE,01-710-1166,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,5,E08,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-03-30,2013-03-20,2013-03-20,111,111
CDISCPILOT01,AE,01-710-1183,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,2,E08,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,NA,HLT_0419,NA,HLGT_0464,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-10,2014-03-10,NA,115,NA
CDISCPILOT01,AE,01-710-1183,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,1,E07,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-10,2014-03-10,NA,115,NA
CDISCPILOT01,AE,01-710-1187,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,1,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-23,2012-12-23,NA,44,NA
CDISCPILOT01,AE,01-710-1235,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,3,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-12,2013-01-29,NA,126,NA
CDISCPILOT01,AE,01-710-1235,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,1,E01,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-19,2012-11-22,2012-12-14,58,80
CDISCPILOT01,AE,01-710-1235,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,2,E02,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-15,2013-01-13,NA,110,NA
CDISCPILOT01,AE,01-710-1249,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,3,E07,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-22,2014-02-23,NA,58,NA
CDISCPILOT01,AE,01-710-1249,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,1,E05,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-22,2014-02-11,2014-02-11,46,46
CDISCPILOT01,AE,01-710-1249,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,2,E06,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-22,2014-02-18,2014-02-18,53,53
CDISCPILOT01,AE,01-710-1249,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,4,E08,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-17,2014-04-24,NA,118,NA
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,5,E12,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-01,2013-09-29,2013-09-29,109,109
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,7,E09,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-12,2013-10-09,2013-10-09,119,119
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,9,E11,CHILLS,CHILLS,NA,CHILLS,NA,HLT_0586,NA,HLGT_0161,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-12,2013-10-11,2013-10-11,121,121
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,4,E07,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-01,2013-09-29,2013-09-29,109,109
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,6,E08,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-12,2013-10-09,2013-10-09,119,119
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,8,E10,COLD SWEAT,COLD SWEAT,NA,COLD SWEAT,NA,HLT_0124,NA,HLGT_0208,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-12,2013-10-11,2013-10-11,121,121
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,1,E13,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-11,2013-07-03,2013-07-05,21,23
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,2,E05,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-03,2013-08-21,NA,70,NA
CDISCPILOT01,AE,01-710-1264,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,3,E06,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-03,2013-08-21,NA,70,NA
CDISCPILOT01,AE,01-710-1270,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,1,E04,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-01,2014-02-23,NA,12,NA
CDISCPILOT01,AE,01-710-1270,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,2,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-01,2014-02-23,NA,12,NA
CDISCPILOT01,AE,01-710-1271,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,3,E07,ATRIAL FIBRILLATION,PAROXYSMAL ATRIAL FIBRILLATIO,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,Y,N,2012-12-02,2012-11-21,2012-11-26,56,61
CDISCPILOT01,AE,01-710-1271,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,4,E06,CARDIAC FAILURE CONGESTIVE,CONGESTIVE HEART FAILURE,NA,CARDIAC FAILURE CONGESTIVE,NA,HLT_0511,NA,HLGT_0413,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,Y,N,2012-12-02,2012-11-22,NA,57,NA
CDISCPILOT01,AE,01-710-1271,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,1,E04,DYSPNOEA,SHORTNESS OF BREATH,NA,DYSPNOEA,NA,HLT_0296,NA,HLGT_0255,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2012-12-02,2012-11-21,2012-11-21,56,56
CDISCPILOT01,AE,01-710-1271,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,5,E08,HYPONATRAEMIA,HYPONATREMIA,NA,HYPONATRAEMIA,NA,HLT_0688,NA,HLGT_0102,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2012-12-02,2012-11-22,2012-11-26,57,61
CDISCPILOT01,AE,01-710-1271,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,2,E05,MYOCARDIAL INFARCTION,MYOCARDIAL INFARCT,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,SEVERE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,Y,N,2012-12-02,2012-11-21,2012-11-21,56,56
CDISCPILOT01,AE,01-710-1278,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,3,E03,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-03,2013-02-24,2013-03-03,63,70
CDISCPILOT01,AE,01-710-1278,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,7,E03,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-10,2013-02-24,2013-03-03,63,70
CDISCPILOT01,AE,01-710-1278,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,4,E04,BURNING SENSATION,BURNING SENSATION,NA,BURNING SENSATION,NA,HLT_0775,NA,HLGT_0456,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-03,2013-02-24,2013-02-26,63,65
CDISCPILOT01,AE,01-710-1278,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,2,E02,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-21,2013-02-07,2013-03-03,46,70
CDISCPILOT01,AE,01-710-1278,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,6,E02,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-10,2013-02-07,2013-03-03,46,70
CDISCPILOT01,AE,01-710-1278,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,1,E01,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-24,2013-01-13,2013-01-19,21,27
CDISCPILOT01,AE,01-710-1278,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,5,E05,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-03,2013-03-02,2013-03-02,69,69
CDISCPILOT01,AE,01-710-1300,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,4,E05,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-19,2013-02-13,NA,61,NA
CDISCPILOT01,AE,01-710-1300,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,3,E04,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-11,2013-02-10,NA,58,NA
CDISCPILOT01,AE,01-710-1300,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,2,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-11,2013-02-10,NA,58,NA
CDISCPILOT01,AE,01-710-1300,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,1,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-11,2013-01-31,NA,48,NA
CDISCPILOT01,AE,01-710-1314,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,1,E01,NASOPHARYNGITIS,COMMON COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-20,2013-05-24,27,31
CDISCPILOT01,AE,01-710-1314,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,2,E01,NASOPHARYNGITIS,COMMON COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-25,2013-05-20,2013-05-24,27,31
CDISCPILOT01,AE,01-710-1315,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,4,E05,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-18,2013-06-18,2013-07-07,112,131
CDISCPILOT01,AE,01-710-1315,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,7,E05,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-16,2013-06-18,2013-07-07,112,131
CDISCPILOT01,AE,01-710-1315,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,1,E02,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-27,2013-02-26,2013-02-26,-1,-1
CDISCPILOT01,AE,01-710-1315,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,2,E03,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-21,2013-05-14,2013-07-07,77,131
CDISCPILOT01,AE,01-710-1315,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,5,E03,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-16,2013-05-14,2013-07-07,77,131
CDISCPILOT01,AE,01-710-1315,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,3,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-18,2013-06-18,2013-07-07,112,131
CDISCPILOT01,AE,01-710-1315,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,6,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-16,2013-06-18,2013-07-07,112,131
CDISCPILOT01,AE,01-710-1354,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,1,E09,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-06,2012-12-30,NA,50,NA
CDISCPILOT01,AE,01-710-1354,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,2,E10,PRURITUS,PRURITUS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-02,2013-02-14,NA,96,NA
CDISCPILOT01,AE,01-710-1358,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,3,E06,APPLICATION SITE DESQUAMATION,APPLICATION SITE DESQUAMATION,NA,APPLICATION SITE DESQUAMATION,NA,HLT_0351,NA,HLGT_0193,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-06,2013-01-24,NA,130,NA
CDISCPILOT01,AE,01-710-1358,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,2,E05,PRURITUS,ITCHY,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-09,2012-12-22,NA,97,NA
CDISCPILOT01,AE,01-710-1358,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,1,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-09,2012-12-22,NA,97,NA
CDISCPILOT01,AE,01-710-1368,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,2,E06,DELUSION,DELUSIONS,NA,DELUSION,NA,HLT_0198,NA,HLGT_0565,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-09,2014-03-26,NA,155,NA
CDISCPILOT01,AE,01-710-1368,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,1,E05,HIP FRACTURE,FRACTURED HIP,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,2014-01-15,2013-12-25,2014-04-24,64,184
CDISCPILOT01,AE,01-710-1368,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,4,E05,HIP FRACTURE,FRACTURED HIP,NA,HIP FRACTURE,NA,HLT_0097,NA,HLGT_0131,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,SEVERE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2014-04-24,2013-12-25,2014-04-24,64,184
CDISCPILOT01,AE,01-710-1368,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,3,E08,PSYCHOMOTOR HYPERACTIVITY,INCREASED ACTIVITY,NA,PSYCHOMOTOR HYPERACTIVITY,NA,HLT_0383,NA,HLGT_0277,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-09,2014-03-26,NA,155,NA
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,7,E12,ATRIAL FIBRILLATION,ATRIAL FIBRILLATION,NA,ATRIAL FIBRILLATION,NA,HLT_0365,NA,HLGT_0012,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-18,2013-02-18,NA,113,NA
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,3,E08,ATRIOVENTRICULAR BLOCK FIRST DEGREE,FIRST DEGREE ATRIOVENTRICULAR,NA,ATRIOVENTRICULAR BLOCK FIRST DEGREE,NA,HLT_0419,NA,HLGT_0464,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-26,2012-11-26,NA,29,NA
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,6,E11,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-21,2012-12-27,NA,60,NA
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,8,E13,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,T WAVE FLATTENING OF,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,NA,HLT_0037,NA,HLGT_0030,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-18,2013-02-18,NA,113,NA
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,4,E09,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-25,2012-12-18,NA,51,NA
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,5,E10,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-21,2012-12-27,NA,60,NA
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,1,E06,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,NA,SUPRAVENTRICULAR TACHYCARDIA,NA,HLT_0692,NA,HLGT_0619,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-12,2012-11-12,2012-11-13,15,16
CDISCPILOT01,AE,01-710-1385,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,2,E06,SUPRAVENTRICULAR TACHYCARDIA,SUPRAVENTRICULAR TACHYCARDIA,NA,SUPRAVENTRICULAR TACHYCARDIA,NA,HLT_0692,NA,HLGT_0619,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-11-26,2012-11-12,2012-11-13,15,16
CDISCPILOT01,AE,01-710-1408,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,3,E07,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-07,2013-02-24,2013-05-31,51,147
CDISCPILOT01,AE,01-710-1408,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,4,E07,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-28,2013-02-24,2013-05-31,51,147
CDISCPILOT01,AE,01-710-1408,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,1,E06,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-07,2013-01-31,2013-02-09,27,36
CDISCPILOT01,AE,01-710-1408,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,2,E06,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-20,2013-01-31,2013-02-09,27,36
CDISCPILOT01,AE,01-711-1012,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,1,E06,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-17,2013-04-16,NA,14,NA
CDISCPILOT01,AE,01-711-1012,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,3,E06,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-02,2013-04-16,NA,14,NA
CDISCPILOT01,AE,01-711-1012,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,2,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-17,2013-04-16,2013-05-02,14,30
CDISCPILOT01,AE,01-711-1012,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,4,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-02,2013-04-16,2013-05-02,14,30
CDISCPILOT01,AE,01-711-1012,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,7,E09,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-17,2013-04-16,2013-05-02,14,30
CDISCPILOT01,AE,01-711-1012,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,6,E08,APPLICATION SITE URTICARIA,APPLICATION SITE URTICARIA,NA,APPLICATION SITE URTICARIA,NA,HLT_0196,NA,HLGT_0233,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-02,2013-04-29,2013-05-01,27,29
CDISCPILOT01,AE,01-711-1012,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,5,E07,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-02,2013-04-27,NA,25,NA
CDISCPILOT01,AE,01-711-1036,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,2,E04,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-12,2012-08-04,2012-08-12,7,15
CDISCPILOT01,AE,01-711-1036,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,4,E04,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-08-29,2012-08-04,2012-08-12,7,15
CDISCPILOT01,AE,01-711-1036,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,3,E05,GLOSSITIS,GLOSSITIS,NA,GLOSSITIS,NA,HLT_0250,NA,HLGT_0427,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-12,2012-08-12,NA,15,NA
CDISCPILOT01,AE,01-711-1036,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,1,E03,HEADACHE,INTERMITTENT HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-07-29,2012-07-29,NA,1,NA
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,8,E19,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-28,2013-05-18,NA,46,NA
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,13,E22,CERUMEN IMPACTION,CERUMEN IMPACTION,NA,CERUMEN IMPACTION,NA,HLT_0018,NA,HLGT_0158,NA,EAR AND LABYRINTH DISORDERS,NA,EAR AND LABYRINTH DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-01,2013-06-01,NA,60,NA
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,12,E23,CONJUNCTIVAL HAEMORRHAGE,SUBCONJUNCTIVAL HEMORRHAGE,NA,CONJUNCTIVAL HAEMORRHAGE,NA,HLT_0013,NA,HLGT_0720,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-01,2013-05-30,NA,58,NA
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,3,E18,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,SEVERE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-29,2013-04-28,2013-05-11,26,39
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,5,E18,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-01,2013-04-28,2013-05-11,26,39
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,6,E18,NASOPHARYNGITIS,COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-15,2013-04-28,2013-05-11,26,39
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,2,E16,PARAESTHESIA ORAL,TINGLING MOUTH,NA,PARAESTHESIA ORAL,NA,HLT_0727,NA,HLGT_0035,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-17,2013-04-11,NA,9,NA
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,9,E20,RASH PRURITIC,ITCHY RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-28,2013-05-27,2013-05-31,55,59
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,11,E20,RASH PRURITIC,ITCHY RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-01,2013-05-27,2013-05-31,55,59
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,4,E24,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-29,2013-04-29,2013-05-15,27,43
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,7,E24,SUPRAVENTRICULAR EXTRASYSTOLES,ECTOPIC ATRIAL BEATS,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-28,2013-04-29,2013-05-15,27,43
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,1,E15,TINNITUS,TINNITUS,NA,TINNITUS,NA,HLT_0570,NA,HLGT_0180,NA,EAR AND LABYRINTH DISORDERS,NA,EAR AND LABYRINTH DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-17,2007-10,NA,NA,NA
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,10,E21,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRAC,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-28,2013-05-28,2013-06-01,56,60
CDISCPILOT01,AE,01-711-1143,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,14,E21,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRAC,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-22,2013-05-28,2013-06-01,56,60
CDISCPILOT01,AE,01-711-1433,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,3,E03,ASTHENIA,WEAKNESS,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-06,2013-02-05,NA,10,NA
CDISCPILOT01,AE,01-711-1433,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,1,E01,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-25,2012-07-23,NA,-18,NA
CDISCPILOT01,AE,01-711-1433,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,2,E01,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-06,2012-07-23,NA,-18,NA
CDISCPILOT01,AE,01-713-1043,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,1,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-30,2013-09-26,NA,12,NA
CDISCPILOT01,AE,01-713-1043,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,4,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-13,2013-09-26,NA,12,NA
CDISCPILOT01,AE,01-713-1043,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,7,E07,CATARACT OPERATION,CATARACT EXTRACTION,NA,CATARACT OPERATION,NA,HLT_0432,NA,HLGT_0058,NA,SURGICAL AND MEDICAL PROCEDURES,NA,SURGICAL AND MEDICAL PROCEDURES,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-24,2014-03-08,2014-03-08,175,175
CDISCPILOT01,AE,01-713-1043,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,2,E04,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-11,2013-10-11,2013-10-11,27,27
CDISCPILOT01,AE,01-713-1043,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,5,E04,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-13,2013-10-11,2013-10-11,27,27
CDISCPILOT01,AE,01-713-1043,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,3,E05,VOMITING,EMESIS,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-11,2013-10-11,2013-10-11,27,27
CDISCPILOT01,AE,01-713-1043,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,6,E05,VOMITING,EMESIS,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-13,2013-10-11,2013-10-11,27,27
CDISCPILOT01,AE,01-713-1073,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,1,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-21,2014-07-14,NA,107,NA
CDISCPILOT01,DM,01-713-1106,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-713-1141,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,3,E04,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-06,2013-06-30,NA,31,NA
CDISCPILOT01,AE,01-713-1141,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,4,E05,DELIRIUM,DELIRIUM,NA,DELIRIUM,NA,HLT_0376,NA,HLGT_0176,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-08-06,2013-07-01,2013-07-15,32,46
CDISCPILOT01,AE,01-713-1141,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,1,E03,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-26,2013-06-21,2013-07-15,22,46
CDISCPILOT01,AE,01-713-1141,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,2,E03,RASH PRURITIC,PRURITIC RASH,NA,RASH PRURITIC,NA,HLT_0127,NA,HLGT_0753,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-06,2013-06-21,2013-07-15,22,46
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,4,E05,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-07,2013-09-05,NA,28,NA
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,6,E05,ASTHENIA,LOWER EXTREMITIES WEAKNESS OF,NA,ASTHENIA,NA,HLT_0205,NA,HLGT_0614,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-19,2013-09-05,NA,28,NA
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,12,E10,CERVICITIS,CERVICITIS,NA,CERVICITIS,NA,HLT_0651,NA,HLGT_0282,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-26,2013-11-23,2013-12-02,107,116
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,14,E10,CERVICITIS,CERVICITIS,NA,CERVICITIS,NA,HLT_0651,NA,HLGT_0282,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-01,2013-11-23,2013-12-02,107,116
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,2,E02,DYSPEPSIA,HEARTBURN,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-24,2013-08-22,2013-08-22,14,14
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,7,E06,DYSPEPSIA,INDIGESTION,NA,DYSPEPSIA,NA,HLT_0244,NA,HLGT_0716,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-19,2013-09-12,NA,35,NA
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,1,E01,DYSURIA,MICTURITION BURNING,NA,DYSURIA,NA,HLT_0637,NA,HLGT_0210,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-24,2013-08-19,2013-08-23,11,15
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,9,E08,GASTROENTERITIS VIRAL,STOMACH FLU,NA,GASTROENTERITIS VIRAL,NA,HLT_0211,NA,HLGT_0385,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-11-06,2013-10-10,2013-10-13,63,66
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,10,E11,GASTROOESOPHAGEAL REFLUX DISEASE,GASTROOESOPHAGEAL REFLUX DISE,NA,GASTROOESOPHAGEAL REFLUX DISEASE,NA,HLT_0407,NA,HLGT_0304,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-06,2013-10-10,NA,63,NA
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,8,E07,PELVIC PAIN,PELVIC PAIN,NA,PELVIC PAIN,NA,HLT_0189,NA,HLGT_0691,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-06,2013-10-10,2014-01-18,63,163
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,15,E07,PELVIC PAIN,PELVIC PAIN,NA,PELVIC PAIN,NA,HLT_0189,NA,HLGT_0691,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,REPRODUCTIVE SYSTEM AND BREAST DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-24,2013-10-10,2014-01-18,63,163
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,3,E04,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-05,2013-08-28,2013-09-08,20,31
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,5,E04,URINARY TRACT INFECTION,URINARY TRACT INFECTION,NA,URINARY TRACT INFECTION,NA,HLT_0161,NA,HLGT_0093,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-19,2013-08-28,2013-09-08,20,31
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,11,E09,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,NA,VAGINAL MYCOSIS,NA,HLT_0508,NA,HLGT_0643,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-26,2013-11-23,2013-12-02,107,116
CDISCPILOT01,AE,01-713-1179,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,13,E09,VAGINAL MYCOSIS,VAGINAL YEAST INFECTION,NA,VAGINAL MYCOSIS,NA,HLT_0508,NA,HLGT_0643,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-01,2013-11-23,2013-12-02,107,116
CDISCPILOT01,AE,01-713-1209,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,1,E05,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-14,2013-05-30,NA,4,NA
CDISCPILOT01,AE,01-713-1209,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,3,E05,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-19,2013-05-30,NA,4,NA
CDISCPILOT01,AE,01-713-1209,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,2,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-14,2013-06-02,NA,7,NA
CDISCPILOT01,AE,01-713-1209,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,4,E08,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-14,2013-10-31,NA,158,NA
CDISCPILOT01,AE,01-713-1256,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,1,E03,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-31,2012-10-30,2012-10-31,42,43
CDISCPILOT01,AE,01-713-1256,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,2,E03,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-11-14,2012-10-30,2012-10-31,42,43
CDISCPILOT01,AE,01-713-1269,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,1,E01,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-10,2014-02-02,NA,7,NA
CDISCPILOT01,AE,01-713-1269,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,2,E02,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-20,2014-04-18,NA,82,NA
CDISCPILOT01,AE,01-713-1269,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,4,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-13,2014-07-10,NA,165,NA
CDISCPILOT01,AE,01-713-1269,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,6,E04,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-28,2014-07-10,NA,165,NA
CDISCPILOT01,AE,01-713-1269,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,3,E03,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-15,2014-06-01,NA,126,NA
CDISCPILOT01,AE,01-713-1269,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,5,E03,SHOULDER PAIN,SHOULDER PAIN,NA,SHOULDER PAIN,NA,HLT_0527,NA,HLGT_0288,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-28,2014-06-01,NA,126,NA
CDISCPILOT01,AE,01-713-1448,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,1,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-14,2014-03-19,2014-05-23,60,125
CDISCPILOT01,AE,01-713-1448,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,3,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-07,2014-03-19,2014-05-23,60,125
CDISCPILOT01,AE,01-713-1448,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,2,E04,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-14,2014-03-27,2014-05-23,68,125
CDISCPILOT01,AE,01-713-1448,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,4,E04,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-07,2014-03-27,2014-05-23,68,125
CDISCPILOT01,AE,01-714-1035,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,7,E09,BRONCHITIS,BRONCHITIS,NA,BRONCHITIS,NA,HLT_0634,NA,HLGT_0523,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-08-06,2014-07-18,2014-07-24,93,99
CDISCPILOT01,AE,01-714-1035,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,1,E04,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANC,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-26,2014-05-26,2014-06-04,40,49
CDISCPILOT01,AE,01-714-1035,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,5,E04,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANC,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-06-17,2014-05-26,2014-06-04,40,49
CDISCPILOT01,AE,01-714-1035,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,4,E07,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-04,2014-06-04,NA,49,NA
CDISCPILOT01,AE,01-714-1035,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,2,E05,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERSION,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-26,2014-05-26,NA,40,NA
CDISCPILOT01,AE,01-714-1035,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,3,E06,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-04,2014-06-04,2014-06-17,49,62
CDISCPILOT01,AE,01-714-1035,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,6,E06,SUPRAVENTRICULAR EXTRASYSTOLES,PREMATURE ATRIAL CONTRACTION,NA,SUPRAVENTRICULAR EXTRASYSTOLES,NA,HLT_0188,NA,HLGT_0279,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-10,2014-06-04,2014-06-17,49,62
CDISCPILOT01,AE,01-714-1068,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,3,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-03,2013-09-20,NA,44,NA
CDISCPILOT01,AE,01-714-1068,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,5,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE ERYTHEMA,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-16,2013-09-20,NA,44,NA
CDISCPILOT01,AE,01-714-1068,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,4,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-03,2013-09-20,NA,44,NA
CDISCPILOT01,AE,01-714-1068,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,6,E07,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-16,2013-09-20,NA,44,NA
CDISCPILOT01,AE,01-714-1068,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,1,E04,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-22,2013-08-12,2013-08-22,5,15
CDISCPILOT01,AE,01-714-1068,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,2,E04,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-09-05,2013-08-12,2013-08-22,5,15
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,3,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-13,2013-07-17,18,83
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,8,E06,APPLICATION SITE ERYTHEMA,APPLICATION SITE REDNESS,NA,APPLICATION SITE ERYTHEMA,NA,HLT_0617,NA,HLGT_0152,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-09,2013-05-13,2013-07-17,18,83
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,5,E08,APPLICATION SITE PRURITUS,APPLICATION SITE PRURITUS,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-17,NA,22,NA
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,1,E04,DIARRHOEA,LOOSE STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-12,2013-07-17,17,83
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,6,E04,DIARRHOEA,LOOSE STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-09,2013-05-12,2013-07-17,17,83
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,9,E09,DYSURIA,URINATION DIFFICULTY,NA,DYSURIA,NA,HLT_0637,NA,HLGT_0210,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-09,2013-07-25,2013-08-06,91,103
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,2,E05,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-12,2013-07-17,17,83
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,7,E05,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-09,2013-05-12,2013-07-17,17,83
CDISCPILOT01,AE,01-714-1195,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,4,E07,SOMNOLENCE,DROWSINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-14,NA,19,NA
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,7,E13,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-01,2014-03-08,NA,95,NA
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,6,E12,BACK PAIN,LOW BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-02,2014-02-24,2014-04-08,83,126
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,8,E12,BACK PAIN,LOW BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-29,2014-02-24,2014-04-08,83,126
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,5,E11,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-02,2014-01-22,2014-01-25,50,53
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,2,E08,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-17,2013-12-14,2013-12-15,11,12
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,1,E07,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-12-17,2013-12-13,2013-12-13,10,10
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,3,E09,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-19,2014-01-11,NA,39,NA
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,4,E10,NASOPHARYNGITIS,HEAD COLD,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-02,2014-01-22,2014-01-25,50,53
CDISCPILOT01,AE,01-714-1288,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,9,E14,SINUS BRADYCARDIA,BRADYCARDIA SINUS,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-27,2014-05-27,NA,175,NA
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,2,E07,EAR PAIN,EAR PAIN,NA,EAR PAIN,NA,HLT_0631,NA,HLGT_0432,NA,EAR AND LABYRINTH DISORDERS,NA,EAR AND LABYRINTH DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-06,2013-04-04,2013-04-15,38,49
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,4,E07,EAR PAIN,EAR PAIN,NA,EAR PAIN,NA,HLT_0631,NA,HLGT_0432,NA,EAR AND LABYRINTH DISORDERS,NA,EAR AND LABYRINTH DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-26,2013-04-04,2013-04-15,38,49
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,6,E09,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-22,2013-06-16,NA,111,NA
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,8,E09,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-23,2013-06-16,NA,111,NA
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,5,E08,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-22,2013-05-29,NA,93,NA
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,7,E08,PRURITUS,PRURITIS,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-23,2013-05-29,NA,93,NA
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,1,E06,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-06,2013-03-30,2013-04-06,33,40
CDISCPILOT01,AE,01-714-1375,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,3,E06,SKIN IRRITATION,IRRITATION SKIN,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-08,2013-03-30,2013-04-06,33,40
CDISCPILOT01,AE,01-714-1425,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,1,E04,ATRIOVENTRICULAR BLOCK SECOND DEGREE,AV BLOCK SECOND DEGREE,NA,ATRIOVENTRICULAR BLOCK SECOND DEGREE,NA,HLT_0415,NA,HLGT_0086,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-13,2013-08-13,NA,-2,NA
CDISCPILOT01,DM,01-715-1085,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-715-1107,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,1,E01,DERMATITIS CONTACT,CONTACT DERMATITIS,NA,DERMATITIS CONTACT,NA,HLT_0056,NA,HLGT_0331,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-13,2013-05-07,2013-05-21,71,85
CDISCPILOT01,AE,01-715-1107,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,3,E01,DERMATITIS CONTACT,CONTACT DERMATITIS,NA,DERMATITIS CONTACT,NA,HLT_0056,NA,HLGT_0331,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-14,2013-05-07,2013-05-21,71,85
CDISCPILOT01,AE,01-715-1107,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,2,E02,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-13,2013-05-13,NA,77,NA
CDISCPILOT01,DM,01-715-1155,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-715-1207,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,1,E01,NEPHROLITHIASIS,KIDNEY STONES,NA,NEPHROLITHIASIS,NA,HLT_0439,NA,HLGT_0546,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-13,2013-01-10,2013-01-10,54,54
CDISCPILOT01,AE,01-715-1319,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,1,E03,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-18,2013-03-18,2013-03-18,30,30
CDISCPILOT01,AE,01-715-1321,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,3,E03,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-22,2014-04-21,NA,70,NA
CDISCPILOT01,AE,01-715-1321,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,1,E02,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-14,2014-03-14,2014-03-14,32,32
CDISCPILOT01,AE,01-715-1321,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,2,E02,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-26,2014-03-14,2014-03-14,32,32
CDISCPILOT01,AE,01-715-1321,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,4,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-22,2014-04-22,NA,71,NA
CDISCPILOT01,DM,01-715-1397,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-715-1405,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,4,E05,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-13,2013-07-08,2013-07-08,3,3
CDISCPILOT01,AE,01-715-1405,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,3,E04,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-13,2013-07-08,2013-07-08,3,3
CDISCPILOT01,AE,01-715-1405,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,2,E03,HYPERHIDROSIS,SWEATING,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-13,2013-07-08,2013-07-08,3,3
CDISCPILOT01,AE,01-715-1405,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,1,E02,PALPITATIONS,PALPITATIONS,NA,PALPITATIONS,NA,HLT_0493,NA,HLGT_0593,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-13,2013-07-08,2013-07-08,3,3
CDISCPILOT01,AE,01-715-1405,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,5,E01,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-13,2013-07-13,2013-07-13,8,8
CDISCPILOT01,AE,01-715-1405,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,6,E01,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-11,2013-07-13,2013-07-13,8,8
CDISCPILOT01,AE,01-716-1024,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,3,E13,EMPHYSEMA,EMPHYSEMA,NA,EMPHYSEMA,NA,HLT_0698,NA,HLGT_0221,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-30,2012-12-16,NA,161,NA
CDISCPILOT01,AE,01-716-1024,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,1,E12,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-08-24,2012-08-20,2012-09-27,43,81
CDISCPILOT01,AE,01-716-1024,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,2,E12,NASOPHARYNGITIS,COLD SYMPTOMS,NA,NASOPHARYNGITIS,NA,HLT_0036,NA,HLGT_0709,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-09-30,2012-08-20,2012-09-27,43,81
CDISCPILOT01,AE,01-716-1026,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,4,E08,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-31,2014-07-16,2014-07-25,106,115
CDISCPILOT01,AE,01-716-1026,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,7,E09,EAR INFECTION,EAR INFECTION,NA,EAR INFECTION,NA,HLT_0757,NA,HLGT_0760,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-08-28,2014-08-15,2014-08-27,136,148
CDISCPILOT01,AE,01-716-1026,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,5,E10,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,T WAVE FLATTENING OF,NA,ELECTROCARDIOGRAM T WAVE AMPLITUDE DEC,NA,HLT_0037,NA,HLGT_0030,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-31,2014-07-31,NA,121,NA
CDISCPILOT01,AE,01-716-1026,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,3,E05,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-18,2014-04-18,2014-07-31,17,121
CDISCPILOT01,AE,01-716-1026,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,6,E05,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-08-28,2014-04-18,2014-07-31,17,121
CDISCPILOT01,AE,01-716-1026,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,1,E06,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-18,2014-04-17,NA,16,NA
CDISCPILOT01,AE,01-716-1026,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,2,E07,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-18,2014-04-17,NA,16,NA
CDISCPILOT01,DM,01-716-1030,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-716-1044,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,3,E05,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-16,2013-10-15,NA,172,NA
CDISCPILOT01,AE,01-716-1044,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,1,E04,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-24,2013-05-21,2013-05-26,25,30
CDISCPILOT01,AE,01-716-1044,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,2,E04,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-05-21,2013-05-26,25,30
CDISCPILOT01,AE,01-716-1063,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,2,E09,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-04,2013-07-01,NA,54,NA
CDISCPILOT01,AE,01-716-1063,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,1,E11,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-09,2013-05-09,NA,366,NA
CDISCPILOT01,AE,01-716-1063,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,6,E10,LETHARGY,LETHARGY,NA,LETHARGY,NA,HLT_0027,NA,HLGT_0448,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-07-31,NA,84,NA
CDISCPILOT01,AE,01-716-1063,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,3,E12,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-04,2013-07-04,2013-07-28,57,81
CDISCPILOT01,AE,01-716-1063,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,4,E12,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-07-04,2013-07-28,57,81
CDISCPILOT01,AE,01-716-1063,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,5,E13,RESTLESSNESS,RESTLESSNESS,NA,RESTLESSNESS,NA,HLT_0427,NA,HLGT_0510,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-07-28,2013-07-31,81,84
CDISCPILOT01,AE,01-716-1063,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,7,E13,RESTLESSNESS,RESTLESSNESS,NA,RESTLESSNESS,NA,HLT_0427,NA,HLGT_0510,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-28,2013-07-28,2013-07-31,81,84
CDISCPILOT01,AE,01-716-1071,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,2,E10,FATIGUE,TIREDNESS,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-26,2013-07-13,NA,36,NA
CDISCPILOT01,AE,01-716-1071,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,1,E09,HYPERSOMNIA,SLEEP EXCESSIVE,NA,HYPERSOMNIA,NA,HLT_0231,NA,HLGT_0628,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-26,2013-07-13,NA,36,NA
CDISCPILOT01,AE,01-716-1071,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,3,E08,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-01,2013-07-31,2013-07-31,54,54
CDISCPILOT01,AE,01-716-1094,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,1,E07,ATRIAL FLUTTER,ATRIAL FLUTTER,NA,ATRIAL FLUTTER,NA,HLT_0477,NA,HLGT_0627,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-19,2013-01-19,NA,32,NA
CDISCPILOT01,AE,01-716-1094,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,2,E08,BUNDLE BRANCH BLOCK RIGHT,INCOMPLETE RIGHT BUNDLE BRANC,NA,BUNDLE BRANCH BLOCK RIGHT,NA,HLT_0751,NA,HLGT_0597,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-19,2013-01-19,NA,32,NA
CDISCPILOT01,AE,01-716-1094,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,3,E09,VENTRICULAR SEPTAL DEFECT,VENTRICULAR SEPTAL DEFECT,NA,VENTRICULAR SEPTAL DEFECT,NA,HLT_0589,NA,HLGT_0747,NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,"CONGENITAL, FAMILIAL AND GENETIC DISORDERS",NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-19,2013-01-19,NA,32,NA
CDISCPILOT01,AE,01-716-1103,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,2,E06,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-23,2014-07-09,2014-07-16,112,119
CDISCPILOT01,AE,01-716-1103,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,4,E08,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-08-19,2014-08-17,2014-08-24,151,158
CDISCPILOT01,AE,01-716-1103,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,5,E08,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-08-30,2014-08-17,2014-08-24,151,158
CDISCPILOT01,AE,01-716-1103,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,3,E07,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-23,2014-07-09,NA,112,NA
CDISCPILOT01,AE,01-716-1103,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,1,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-07-23,2014-07-09,NA,112,NA
CDISCPILOT01,AE,01-716-1108,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,1,E04,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,ST SEGMENT DEPRESSED,NA,ELECTROCARDIOGRAM ST SEGMENT DEPRESSIO,NA,HLT_0610,NA,HLGT_0220,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-12,2013-04-12,NA,60,NA
CDISCPILOT01,AE,01-716-1108,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,2,E05,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-10,2013-05-01,NA,79,NA
CDISCPILOT01,AE,01-716-1151,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,3,E07,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-15,2013-03-15,NA,43,NA
CDISCPILOT01,AE,01-716-1151,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,1,E05,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOM,NA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,HLT_0245,NA,HLGT_0507,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,Y,N,N,N,N,N,N,2013-02-27,2013-02-19,2013-03-22,19,50
CDISCPILOT01,AE,01-716-1151,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,4,E05,MALIGNANT FIBROUS HISTIOCYTOMA,MALIGNANT FIBROUS HISTIOCYTOM,NA,MALIGNANT FIBROUS HISTIOCYTOMA,NA,HLT_0245,NA,HLGT_0507,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,Y,N,N,N,N,N,N,2013-04-02,2013-02-19,2013-03-22,19,50
CDISCPILOT01,AE,01-716-1151,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,2,E06,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-15,2013-03-15,NA,43,NA
CDISCPILOT01,AE,01-716-1157,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,2,E06,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-04,2013-10-25,NA,24,NA
CDISCPILOT01,AE,01-716-1157,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,3,E07,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-04,2013-10-25,NA,24,NA
CDISCPILOT01,AE,01-716-1157,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,1,E05,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-04,2013-10-17,2013-11-04,16,34
CDISCPILOT01,AE,01-716-1157,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,4,E05,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-06,2013-10-17,2013-11-04,16,34
CDISCPILOT01,AE,01-716-1160,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,2,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-09,NA,35,NA
CDISCPILOT01,AE,01-716-1160,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,1,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-09,NA,35,NA
CDISCPILOT01,AE,01-716-1167,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,3,E05,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-03,2012-12-03,NA,57,NA
CDISCPILOT01,AE,01-716-1167,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,4,E06,HYPERSENSITIVITY,ALLERGY,NA,HYPERSENSITIVITY,NA,HLT_0473,NA,HLGT_0765,NA,IMMUNE SYSTEM DISORDERS,NA,IMMUNE SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-24,2013-03-10,2013-04-10,154,185
CDISCPILOT01,AE,01-716-1167,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,5,E06,HYPERSENSITIVITY,ALLERGY,NA,HYPERSENSITIVITY,NA,HLT_0473,NA,HLGT_0765,NA,IMMUNE SYSTEM DISORDERS,NA,IMMUNE SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-13,2013-03-10,2013-04-10,154,185
CDISCPILOT01,AE,01-716-1167,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,1,E03,PRURITUS,ITCH,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-19,2012-11-17,NA,41,NA
CDISCPILOT01,AE,01-716-1167,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,2,E04,SWELLING,SWELLING,NA,SWELLING,NA,HLT_0658,NA,HLGT_0484,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-19,2012-11-17,NA,41,NA
CDISCPILOT01,AE,01-716-1177,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,1,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-10-20,2014-08-24,NA,-9,NA
CDISCPILOT01,AE,01-716-1189,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,2,E05,DELUSION,DELUSIONS,NA,DELUSION,NA,HLT_0198,NA,HLGT_0565,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-27,2012-11-24,NA,47,NA
CDISCPILOT01,AE,01-716-1189,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,1,E04,HALLUCINATION,HALLUCINATION,NA,HALLUCINATION,NA,HLT_0026,NA,HLGT_0649,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-27,2012-11-24,NA,47,NA
CDISCPILOT01,AE,01-716-1189,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,4,E07,PROSTATE CANCER,PROSTATE CANCER,NA,PROSTATE CANCER,NA,HLT_0412,NA,HLGT_0190,NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,"NEOPLASMS BENIGN, MALIGNANT AND UNSPECIFIED (INCL CYST",NA,SEVERE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,Y,N,N,N,N,N,N,2013-03-03,2013-02-07,NA,122,NA
CDISCPILOT01,AE,01-716-1189,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,3,E06,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-05,2013-01-05,NA,89,NA
CDISCPILOT01,AE,01-716-1229,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,2,E03,BLOOD CHOLESTEROL INCREASED,HIGH CHOLESTEROL,NA,BLOOD CHOLESTEROL INCREASED,NA,HLT_0210,NA,HLGT_0430,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-06,2013-03-06,NA,15,NA
CDISCPILOT01,AE,01-716-1229,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,1,E01,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-20,2013-02-20,NA,1,NA
CDISCPILOT01,AE,01-716-1298,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,3,E07,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-06,2013-06-08,2013-07-06,62,90
CDISCPILOT01,AE,01-716-1298,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,6,E07,BLISTER,BLISTERS,NA,BLISTER,NA,HLT_0752,NA,HLGT_0267,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-07,2013-06-08,2013-07-06,62,90
CDISCPILOT01,AE,01-716-1298,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,1,E05,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-22,2013-04-22,2013-07-06,15,90
CDISCPILOT01,AE,01-716-1298,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,4,E05,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-07,2013-04-22,2013-07-06,15,90
CDISCPILOT01,AE,01-716-1298,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,2,E06,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-22,2013-04-22,2013-07-06,15,90
CDISCPILOT01,AE,01-716-1298,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,5,E06,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-07,2013-04-22,2013-07-06,15,90
CDISCPILOT01,AE,01-716-1308,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,1,E01,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-23,2013-09-20,NA,24,NA
CDISCPILOT01,AE,01-716-1311,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,2,E07,ABDOMINAL PAIN,ABDOMINAL PAIN,NA,ABDOMINAL PAIN,NA,HLT_0217,NA,HLGT_0419,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-08-07,2014-07-22,2014-08-02,70,81
CDISCPILOT01,AE,01-716-1311,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,1,E06,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-11,2014-05-28,2014-09-22,15,132
CDISCPILOT01,AE,01-716-1311,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,4,E06,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-09-30,2014-05-28,2014-09-22,15,132
CDISCPILOT01,AE,01-716-1311,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,3,E08,ULCER,ULCER,NA,ULCER,NA,HLT_0040,NA,HLGT_0245,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-08-07,2014-08-02,NA,81,NA
CDISCPILOT01,AE,01-716-1364,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,2,E05,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-02,2013-09-02,NA,61,NA
CDISCPILOT01,AE,01-716-1364,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,1,E04,PRURITUS,ITCH,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-18,2013-08-18,NA,46,NA
CDISCPILOT01,AE,01-716-1373,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,1,E05,COGNITIVE DISORDER,COGNITIVE IMPAIRMENT,NA,COGNITIVE DISORDER,NA,HLT_0265,NA,HLGT_0506,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-14,2012-12-14,NA,1,NA
CDISCPILOT01,AE,01-716-1373,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,2,E04,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-12-30,2012-12-15,NA,2,NA
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,2,E03,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-19,2013-05-05,NA,1,NA
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,5,E05,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-22,2013-07,2013-09-26,NA,145
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,7,E05,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-05,2013-07,2013-09-26,NA,145
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,9,E07,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-05,2013-09-26,2013-11-11,145,191
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,10,E07,HEADACHE,HEADACHE,NA,HEADACHE,NA,HLT_0064,NA,HLGT_0344,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-20,2013-09-26,2013-11-11,145,191
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,4,E02,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-19,2013-05-07,NA,3,NA
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,1,E08,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-05,2013-05-05,2013-05-07,1,3
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,3,E08,URTICARIA,WELTS,NA,URTICARIA,NA,HLT_0420,NA,HLGT_0705,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-19,2013-05-05,2013-05-07,1,3
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,6,E06,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-22,2013-07,2013-10-04,NA,153
CDISCPILOT01,AE,01-716-1418,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,8,E06,VISION BLURRED,BLURRED VISION,NA,VISION BLURRED,NA,HLT_0120,NA,HLGT_0598,NA,EYE DISORDERS,NA,EYE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-05,2013-07,2013-10-04,NA,153
CDISCPILOT01,AE,01-716-1441,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,1,E06,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-19,2014-05-11,NA,110,NA
CDISCPILOT01,AE,01-716-1447,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,5,E10,CHEST PAIN,CHEST PAIN,NA,CHEST PAIN,NA,HLT_0717,NA,HLGT_0195,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-12,2014-04-05,2014-04-09,111,115
CDISCPILOT01,AE,01-716-1447,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,4,E08,ELECTROCARDIOGRAM T WAVE INVERSION,T WAVE INVERTED,NA,ELECTROCARDIOGRAM T WAVE INVERSION,NA,HLT_0289,NA,HLGT_0130,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-14,2014-03-14,NA,89,NA
CDISCPILOT01,AE,01-716-1447,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,2,E07,ERYTHEMA,ERYTHEMA,NA,ERYTHEMA,NA,HLT_0284,NA,HLGT_0192,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-27,2014-01-14,NA,30,NA
CDISCPILOT01,AE,01-716-1447,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,1,E06,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-11,2014-01-01,NA,17,NA
CDISCPILOT01,AE,01-716-1447,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,3,E09,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-27,2014-01-14,NA,30,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,7,E11,ANXIETY,ANXIETY,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-28,2014-01-15,NA,2,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,17,E20,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-03,2014-05-21,NA,128,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,3,E06,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-28,2014-01-15,2014-02-18,2,36
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,12,E06,COUGH,COUGH,NA,COUGH,NA,HLT_0701,NA,HLGT_0280,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-25,2014-01-15,2014-02-18,2,36
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,2,E16,DIARRHOEA,SOFT STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-14,2014-01-13,2014-02-10,-1,28
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,10,E16,DIARRHOEA,SOFT STOOLS,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-11,2014-01-13,2014-02-10,-1,28
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,1,E09,ENURESIS,BED WETTING,NA,ENURESIS,NA,HLT_0107,NA,HLGT_0623,NA,RENAL AND URINARY DISORDERS,NA,RENAL AND URINARY DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-14,2013-05,NA,NA,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,5,E08,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-28,2014-01-15,NA,2,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,8,E12,IRRITABILITY,IRRITABILITY,NA,IRRITABILITY,NA,HLT_0627,NA,HLGT_0461,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-28,2014-01-15,NA,2,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,4,E07,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-28,2014-01-15,2014-02-08,2,26
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,9,E07,RHINORRHOEA,RUNNY NOSE,NA,RHINORRHOEA,NA,HLT_0635,NA,HLGT_0460,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-09,2014-01-15,2014-02-08,2,26
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,15,E18,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-08,2014-04-08,NA,85,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,6,E10,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-28,2014-01-15,2014-02-09,2,27
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,11,E10,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-11,2014-01-15,2014-02-09,2,27
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,13,E17,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-11,2014-03-09,2014-03-15,55,61
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,14,E17,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-04-08,2014-03-09,2014-03-15,55,61
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,16,E19,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-05-06,2014-04-21,NA,98,NA
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,18,E21,WOUND,WOUND NOS,NA,WOUND,NA,HLT_0542,NA,HLGT_0540,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-06-03,2014-06-03,2014-06-10,141,148
CDISCPILOT01,AE,01-717-1004,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,19,E21,WOUND,WOUND NOS,NA,WOUND,NA,HLT_0542,NA,HLGT_0540,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-01,2014-06-03,2014-06-10,141,148
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,4,E06,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-23,2014-02-20,NA,25,NA
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,3,E08,HYPERHIDROSIS,SWEATING INCREASED,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-23,2014-02-15,2014-02-17,20,22
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,1,E03,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-10,2014-01-29,2014-07-16,3,171
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,8,E03,INCREASED APPETITE,INCREASED APPETITE,NA,INCREASED APPETITE,NA,HLT_0566,NA,HLGT_0769,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-07-18,2014-01-29,2014-07-16,3,171
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,5,E10,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-23,2014-02-22,NA,27,NA
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,6,E09,PRURITUS GENERALISED,GENERALIZED PRURITUS,NA,PRURITUS GENERALISED,NA,HLT_0123,NA,HLGT_0689,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-03-10,2014-03-04,NA,37,NA
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,2,E07,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-23,2014-02-15,NA,20,NA
CDISCPILOT01,AE,01-717-1109,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,7,E11,VENTRICULAR EXTRASYSTOLES,PREMATURE VENTRICULAR CONTRAC,NA,VENTRICULAR EXTRASYSTOLES,NA,HLT_0050,NA,HLGT_0594,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-04-18,2014-04-18,NA,82,NA
CDISCPILOT01,AE,01-717-1174,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,3,E07,INSOMNIA,INSOMNIA,NA,INSOMNIA,NA,HLT_0297,NA,HLGT_0469,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-18,2013-04-17,2013-04-19,86,88
CDISCPILOT01,AE,01-717-1174,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,2,E04,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-04,2013-02-03,NA,13,NA
CDISCPILOT01,AE,01-717-1174,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,6,E04,PRURITUS,ITCHING,NA,PRURITUS,NA,HLT_0778,NA,HLGT_0695,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-07,2013-02-03,NA,13,NA
CDISCPILOT01,AE,01-717-1174,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,4,E06,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SEVERE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-18,2013-04-25,2013-04-26,94,95
CDISCPILOT01,AE,01-717-1174,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,1,E03,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-04,2013-01-26,NA,5,NA
CDISCPILOT01,AE,01-717-1174,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,5,E03,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-07,2013-01-26,NA,5,NA
CDISCPILOT01,AE,01-717-1201,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,2,E07,ALOPECIA,HAIR LOSS,NA,ALOPECIA,NA,HLT_0077,NA,HLGT_0234,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-17,2014-01-15,NA,28,NA
CDISCPILOT01,AE,01-717-1201,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,1,E06,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-03,2013-12-19,NA,1,NA
CDISCPILOT01,AE,01-717-1344,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,2,E04,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-07,2014-02-01,2014-02-18,22,39
CDISCPILOT01,AE,01-717-1344,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,3,E04,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-19,2014-02-01,2014-02-18,22,39
CDISCPILOT01,AE,01-717-1344,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,1,E03,NASAL CONGESTION,NOSE CONGESTION,NA,NASAL CONGESTION,NA,HLT_0118,NA,HLGT_0549,NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,"RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS",NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-02-07,2014-02-01,2014-02-06,22,27
CDISCPILOT01,AE,01-717-1344,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,4,E05,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-14,2014-02-28,2014-03-01,49,50
CDISCPILOT01,AE,01-717-1344,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,5,E06,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-14,2014-02-28,2014-03-01,49,50
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,4,E08,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-13,2013-06-11,2013-10-15,42,168
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,9,E08,APPLICATION SITE PERSPIRATION,APPLICATION SITE PERSPIRATION,NA,APPLICATION SITE PERSPIRATION,NA,HLT_0283,NA,HLGT_0403,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-20,2013-06-11,2013-10-15,42,168
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,1,E04,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-15,1994-04,NA,NA,NA
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,8,E12,DIZZINESS,DIZZINESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-21,2013-08-10,2013-08-10,102,102
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,7,E11,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-24,2013-07-22,2013-07-22,83,83
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,3,E09,OEDEMA PERIPHERAL,ANKLE EDEMA,NA,OEDEMA PERIPHERAL,NA,HLT_0661,NA,HLGT_0137,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-29,2013-05-29,NA,29,NA
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,2,E07,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-29,2013-05-23,NA,23,NA
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,5,E07,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-19,2013-05-23,NA,23,NA
CDISCPILOT01,AE,01-717-1357,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,6,E10,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-24,2013-07-07,2013-07-08,68,69
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,1,E01,ANXIETY,ANXIETY AGGRAVATED,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-16,2013-09-15,2013-09-16,15,16
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,2,E01,ANXIETY,ANXIETY AGGRAVATED,NA,ANXIETY,NA,HLT_0559,NA,HLGT_0570,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-06,2013-09-15,2013-09-16,15,16
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,7,E07,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-01-19,2014-01-13,2014-01-14,135,136
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,8,E08,PAIN,STINGING,NA,PAIN,NA,HLT_0314,NA,HLGT_0478,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-16,2014-01-28,NA,150,NA
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,5,E06,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-08,2013-10-07,2013-10-11,37,41
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,6,E06,RASH,RASH,NA,RASH,NA,HLT_0762,NA,HLGT_0198,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-16,2013-10-07,2013-10-11,37,41
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,4,E03,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-06,2013-10-06,2014-03-03,36,184
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,9,E03,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-04,2013-10-06,2014-03-03,36,184
CDISCPILOT01,AE,01-717-1446,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,3,E04,SKIN IRRITATION,SKIN IRRITATION,NA,SKIN IRRITATION,NA,HLT_0583,NA,HLGT_0384,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-06,2013-09-19,NA,19,NA
CDISCPILOT01,AE,01-718-1066,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,2,E11,AGITATION,AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-30,2013-07-18,NA,12,NA
CDISCPILOT01,AE,01-718-1066,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,4,E10,INFLAMMATION,INFLAMMATION LOCALIZED,NA,INFLAMMATION,NA,HLT_0582,NA,HLGT_0004,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-30,2013-07-30,NA,24,NA
CDISCPILOT01,AE,01-718-1066,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,1,E07,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-07-30,2013-07-16,2013-07-20,10,14
CDISCPILOT01,AE,01-718-1066,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,3,E08,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,Y,N,N,2013-07-30,2013-07-30,NA,24,NA
CDISCPILOT01,AE,01-718-1079,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,2,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-15,2012-10-05,NA,17,NA
CDISCPILOT01,AE,01-718-1079,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,3,E03,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,SEVERE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-11-06,2012-10-05,NA,17,NA
CDISCPILOT01,AE,01-718-1079,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,1,E02,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2012-10-15,2012-10-05,NA,17,NA
CDISCPILOT01,AE,01-718-1101,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,3,E05,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-12,2013-04-14,2013-07-06,57,140
CDISCPILOT01,AE,01-718-1101,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,6,E05,HYPERHIDROSIS,PERSPIRATION EXCESSIVE,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-02,2013-04-14,2013-07-06,57,140
CDISCPILOT01,AE,01-718-1101,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,5,E06,MYOCARDIAL INFARCTION,INFERIOR MYOCARDIAL INFARCTIO,NA,MYOCARDIAL INFARCTION,NA,HLT_0649,NA,HLGT_0688,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-06,2013-07-06,NA,140,NA
CDISCPILOT01,AE,01-718-1101,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,2,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-13,2013-04-13,2013-05-12,56,85
CDISCPILOT01,AE,01-718-1101,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,4,E04,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-14,2013-04-13,2013-05-12,56,85
CDISCPILOT01,AE,01-718-1101,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,1,E03,VOMITING,VOMITING,NA,VOMITING,NA,HLT_0016,NA,HLGT_0350,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-14,2013-03-06,2013-03-06,18,18
CDISCPILOT01,AE,01-718-1139,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,3,E07,DIARRHOEA,DIARRHEA,NA,DIARRHOEA,NA,HLT_0148,NA,HLGT_0588,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-17,2013-11-16,2013-11-16,182,182
CDISCPILOT01,AE,01-718-1139,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,1,E06,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-15,2013-06-03,2013-07-16,16,59
CDISCPILOT01,AE,01-718-1139,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,2,E06,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-15,2013-06-03,2013-07-16,16,59
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,3,E04,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-17,2013-03-15,2013-03-15,56,56
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,8,E07,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-07,2013-06-16,NA,149,NA
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,1,E05,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-16,2013-02-16,2013-03-17,29,58
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,4,E05,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-12,2013-02-16,2013-03-17,29,58
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,6,E06,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-10,2013-05-10,2013-07-07,112,170
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,9,E06,BRADYCARDIA,BRADYCARDIA,NA,BRADYCARDIA,NA,HLT_0640,NA,HLGT_0294,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-05-10,2013-07-07,112,170
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,7,E08,FOOD CRAVING,CARBOHYDRATE CRAVING,NA,FOOD CRAVING,NA,HLT_0754,NA,HLGT_0376,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-07,2013-06-09,NA,142,NA
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,10,E09,SINUS BRADYCARDIA,SINUS BRADYCARDIA,NA,SINUS BRADYCARDIA,NA,HLT_0644,NA,HLGT_0500,NA,CARDIAC DISORDERS,NA,CARDIAC DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-31,2013-07-31,NA,194,NA
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,2,E03,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-17,2013-03-06,2013-03-26,47,67
CDISCPILOT01,AE,01-718-1150,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,5,E03,UPPER RESPIRATORY TRACT INFECTION,UPPER RESPIRATORY INFECTION,NA,UPPER RESPIRATORY TRACT INFECTION,NA,HLT_0520,NA,HLGT_0489,NA,INFECTIONS AND INFESTATIONS,NA,INFECTIONS AND INFESTATIONS,NA,MODERATE,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-12,2013-03-06,2013-03-26,47,67
CDISCPILOT01,AE,01-718-1170,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,6,E04,AGITATION,INCREASED AGITATION,NA,AGITATION,NA,HLT_0140,NA,HLGT_0170,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,SEVERE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-03,2013-10-16,NA,31,NA
CDISCPILOT01,AE,01-718-1170,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,3,E06,BODY TEMPERATURE INCREASED,TEMPERATURE ELEVATION,NA,BODY TEMPERATURE INCREASED,NA,HLT_0734,NA,HLGT_0351,NA,INVESTIGATIONS,NA,INVESTIGATIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-03,2013-10-11,2013-10-12,26,27
CDISCPILOT01,AE,01-718-1170,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,1,E02,DIZZINESS,LIGHTHEADEDNESS,NA,DIZZINESS,NA,HLT_0619,NA,HLGT_0751,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-03,2013-10-07,2013-10-07,22,22
CDISCPILOT01,AE,01-718-1170,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,2,E05,HYPERHIDROSIS,DIAPHORESIS,NA,HYPERHIDROSIS,NA,HLT_0587,NA,HLGT_0005,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-03,2013-10-11,2013-10-12,26,27
CDISCPILOT01,AE,01-718-1170,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,4,E07,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-03,2013-10-11,2013-10-12,26,27
CDISCPILOT01,AE,01-718-1170,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,5,E03,SYNCOPE,SYNCOPE,NA,SYNCOPE,NA,HLT_0440,NA,HLGT_0310,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,Y,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-11-03,2013-10-12,2013-10-13,27,28
CDISCPILOT01,DM,01-718-1172,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,9,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-01-11,2013-12-29,2014-02-19,100,152
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,10,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2014-02-08,2013-12-29,2014-02-19,100,152
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,11,E06,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2014-03-08,2013-12-29,2014-02-19,100,152
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,1,E02,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-17,2013-10-09,2013-11-15,19,56
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,4,E02,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-19,2013-10-09,2013-11-15,19,56
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,6,E02,BALANCE DISORDER,UNSTEADINESS,NA,BALANCE DISORDER,NA,HLT_0541,NA,HLGT_0101,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-16,2013-10-09,2013-11-15,19,56
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,3,E04,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-10-17,2013-10-15,2013-11-02,25,43
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,5,E04,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-02,2013-10-15,2013-11-02,25,43
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,7,E04,CONTUSION,BRUISING OF FACE,NA,CONTUSION,NA,HLT_0713,NA,HLGT_0381,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-16,2013-10-15,2013-11-02,25,43
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,8,E05,COORDINATION ABNORMAL,INCOORDINATION,NA,COORDINATION ABNORMAL,NA,HLT_0315,NA,HLGT_0015,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-11-16,2013-11-15,2013-11-15,56,56
CDISCPILOT01,AE,01-718-1250,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,2,E03,FALL,FALL,NA,FALL,NA,HLT_0168,NA,HLGT_0446,NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,"INJURY, POISONING AND PROCEDURAL COMPLICATIONS",NA,MILD,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-17,2013-10-09,2013-10-09,19,19
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,4,E02,APPLICATION SITE DISCOLOURATION,APPLICATION SITE DISCOLORATIO,NA,APPLICATION SITE DISCOLOURATION,NA,HLT_0121,NA,HLGT_0273,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-20,2013-08-13,NA,35,NA
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,5,E03,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-20,2013-08-13,NA,35,NA
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,1,E07,ARTHRALGIA,PAIN IN HIP,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-25,2013-07-13,NA,4,NA
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,2,E01,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-25,2013-07-25,2013-07-25,16,16
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,3,E01,ARTHRALGIA,KNEE PAIN,NA,ARTHRALGIA,NA,HLT_0375,NA,HLGT_0610,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-06,2013-07-25,2013-07-25,16,16
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,9,E09,DYSPHAGIA,SWALLOWING DIFFICULT,NA,DYSPHAGIA,NA,HLT_0563,NA,HLGT_0405,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,NA,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-26,2013-10-31,NA,114,NA
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,8,E08,FOOD CRAVING,CARBOHYDRATE CRAVING,NA,FOOD CRAVING,NA,HLT_0754,NA,HLGT_0376,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,NA,NA,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-11-26,2013-10-31,NA,114,NA
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,6,E06,SOMNOLENCE,SOMNOLENCE,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-09-05,2013-09-03,2013-09-19,56,72
CDISCPILOT01,AE,01-718-1254,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,7,E06,SOMNOLENCE,SOMNOLENCE,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-10-03,2013-09-03,2013-09-19,56,72
CDISCPILOT01,AE,01-718-1328,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,1,E07,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-04,2013-03-23,2013-03-25,51,53
CDISCPILOT01,AE,01-718-1328,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,2,E08,APPLICATION SITE IRRITATION,APPLICATION SITE BURNING,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-04-04,2013-03-23,2013-03-25,51,53
CDISCPILOT01,AE,01-718-1328,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,3,E09,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-04,2013-04-02,2013-04-21,61,80
CDISCPILOT01,AE,01-718-1328,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,4,E09,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-01,2013-04-02,2013-04-21,61,80
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,5,E09,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-04-27,2013-04-27,59,59
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,6,E08,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-12,2013-05-12,74,74
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,7,E07,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-16,2013-05-16,78,78
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,8,E10,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-23,2013-05-20,2013-05-20,82,82
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,10,E13,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-07-18,2013-06-23,2013-08-13,116,167
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,11,E13,APPLICATION SITE REACTION,APPLICATION SITE REACTION,NA,APPLICATION SITE REACTION,NA,HLT_0339,NA,HLGT_0668,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-15,2013-06-23,2013-08-13,116,167
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,4,E06,CONFUSIONAL STATE,CONFUSION,NA,CONFUSIONAL STATE,NA,HLT_0642,NA,HLGT_0329,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-25,2013-04-17,NA,49,NA
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,3,E03,DERMATITIS ATOPIC,ATOPIC DERMATITIS,NA,DERMATITIS ATOPIC,NA,HLT_0480,NA,HLGT_0257,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-04-25,1982,NA,NA,NA
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,12,E14,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MODERATE,N,NA,REMOTE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-15,2013-08-15,2013-08-29,169,183
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,13,E14,HYPERTENSION,HYPERTENSION,NA,HYPERTENSION,NA,HLT_0228,NA,HLGT_0476,NA,VASCULAR DISORDERS,NA,VASCULAR DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-08-29,2013-08-15,2013-08-29,169,183
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,1,E05,SKIN ULCER,SKIN EROSION,NA,SKIN ULCER,NA,HLT_0005,NA,HLGT_0017,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-03-16,2013-03-08,2013-03-22,9,23
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,2,E05,SKIN ULCER,SKIN EROSION,NA,SKIN ULCER,NA,HLT_0005,NA,HLGT_0017,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,SKIN AND SUBCUTANEOUS TISSUE DISORDERS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-03-28,2013-03-08,2013-03-22,9,23
CDISCPILOT01,AE,01-718-1355,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,9,E11,SOMNOLENCE,SLEEPINESS,NA,SOMNOLENCE,NA,HLT_0160,NA,HLGT_0254,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-06-20,2013-05-25,NA,87,NA
CDISCPILOT01,AE,01-718-1371,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,3,E08,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-05-24,2013-05-24,NA,29,NA
CDISCPILOT01,AE,01-718-1371,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,6,E08,APPLICATION SITE IRRITATION,APPLICATION SITE IRRITATION,NA,APPLICATION SITE IRRITATION,NA,HLT_0061,NA,HLGT_0346,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-08-08,2013-05-24,NA,29,NA
CDISCPILOT01,AE,01-718-1371,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,1,E06,FATIGUE,FATIGUE,NA,FATIGUE,NA,HLT_0043,NA,HLGT_0181,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-24,2013-05-09,2013-05-11,14,16
CDISCPILOT01,AE,01-718-1371,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,5,E13,"HALLUCINATION, VISUAL",VISUAL HALLUCINATIONS,NA,"HALLUCINATION, VISUAL",NA,HLT_0369,NA,HLGT_0663,NA,PSYCHIATRIC DISORDERS,NA,PSYCHIATRIC DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-20,2013-06-02,2013-06-03,38,39
CDISCPILOT01,AE,01-718-1371,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,2,E07,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MILD,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-05-24,2013-05-09,2013-05-11,14,16
CDISCPILOT01,AE,01-718-1371,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,4,E11,PARTIAL SEIZURES WITH SECONDARY GENERA,PARTIAL SEIZURES WITH SECONDA,NA,PARTIAL SEIZURES WITH SECONDARY GENERA,NA,HLT_0603,NA,HLGT_0719,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,SEVERE,Y,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,Y,N,N,2013-06-20,2013-06-02,2013-06-05,38,41
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,3,E07,AMNESIA,SHORT-TERM MEMORY LOSS,NA,AMNESIA,NA,HLT_0501,NA,HLGT_0641,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-17,2013-01-01,2013-01-19,16,34
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,7,E07,AMNESIA,SHORT-TERM MEMORY LOSS,NA,AMNESIA,NA,HLT_0501,NA,HLGT_0641,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-28,2013-01-01,2013-01-19,16,34
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,10,E11,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-28,2013-01-27,2013-01-27,42,42
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,12,E13,APPLICATION SITE DERMATITIS,APPLICATION SITE RASH,NA,APPLICATION SITE DERMATITIS,NA,HLT_0343,NA,HLGT_0241,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MILD,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-18,2013-01-29,NA,44,NA
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,9,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-01-28,2013-01-27,2013-01-28,42,43
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,11,E10,APPLICATION SITE PRURITUS,APPLICATION SITE ITCHING,NA,APPLICATION SITE PRURITUS,NA,HLT_0317,NA,HLGT_0338,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS,NA,MODERATE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-02-18,2013-01-27,2013-01-28,42,43
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,1,E04,BACK PAIN,BACK PAIN,NA,BACK PAIN,NA,HLT_0115,NA,HLGT_0508,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MUSCULOSKELETAL AND CONNECTIVE TISSUE DISORDERS,NA,MILD,N,NA,NONE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-31,2012-12-18,2012-12-18,2,2
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,13,E14,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-18,2013-02-04,2013-02-25,50,71
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,15,E14,DECREASED APPETITE,DECREASED APPETITE,NA,DECREASED APPETITE,NA,HLT_0574,NA,HLGT_0231,NA,METABOLISM AND NUTRITION DISORDERS,NA,METABOLISM AND NUTRITION DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-03,2013-02-04,2013-02-25,50,71
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,5,E08,LETHARGY,LETHARGY,NA,LETHARGY,NA,HLT_0027,NA,HLGT_0448,NA,NERVOUS SYSTEM DISORDERS,NA,NERVOUS SYSTEM DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-17,2013-01-05,2013-01-05,20,20
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,2,E05,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,REMOTE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2012-12-31,2012-12-26,2012-12-26,10,10
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,4,E06,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-17,2013-01-03,2013-01-09,18,24
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,6,E09,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-17,2013-01-16,2013-01-16,31,31
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,8,E12,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,SEVERE,N,NA,PROBABLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-01-28,2013-01-21,2013-01-24,36,39
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,14,E15,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,NOT RECOVERED/NOT RESOLVED,N,N,N,N,N,N,N,2013-02-18,2013-02-04,2013-02-25,50,71
CDISCPILOT01,AE,01-718-1427,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,16,E15,NAUSEA,NAUSEA,NA,NAUSEA,NA,HLT_0742,NA,HLGT_0326,NA,GASTROINTESTINAL DISORDERS,NA,GASTROINTESTINAL DISORDERS,NA,MODERATE,N,NA,POSSIBLE,RECOVERED/RESOLVED,N,N,N,N,N,N,N,2013-06-03,2013-02-04,2013-02-25,50,71
